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ABSTRACT
The chromatin regulator MLLT3 recognizes target genes through the YEATS domain
that identifies post-translationally modified histones, with preference for crotonyl and acetyl
marks, and recruits different multiprotein effector complexes through its C-terminal domain to
target genes. To study the role of MLLT3 in gene regulation, the Zeleznik-Le and Hemenway
labs developed Mllt3 whole-body knockout (Mllt3;Rosa26-CreERT2) mice. These mice have a
hematopoietic stem cell phenotype and an unexpected obesity and hepatic steatosis phenotype. It
was unknown whether these phenotypes were from liver intrinsic effects or influenced by other
parts of the body. To study this fatty liver phenotype further, Mllt3;Alb-Cre were generated that
have a liver specific Mllt3 knockout. RNA-sequencing was done livers isolated from these mice
aged around 13 weeks. Bioinformatic Gene Ontology Pathway (GO) Analysis of the RNAsequencing data identified significant changes in the expression of hexose and monosaccharide
metabolism genes following Mllt3 deletion in male but not female mice. Based on the RNAsequencing and Gene Ontology Results, we hypothesized that Mllt3 regulates hexose and
monosaccharide metabolic processes and mitochondrial function within the liver. For my thesis
project, more detailed quantitative RT-PCR of the differentially expressed genes in these
pathways identified age and sex related expression changes in Mllt3;Alb-Cre mice. Changes in
mitochondrial function and quantity were also studied in the context of an Mllt3 liver specific
knockout. Mitochondrial function, tested by Seahorse Assays, indicated no significant alteration
in primary liver tissue from Mllt3;Alb-Cre mice at one year of age. There was a change in
mitochondrial quantity following Mllt3 deletion, with age and sex differences as well. Overall, a
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liver specific Mllt3 knockout affects hexose metabolism and mitochondrial quantity with age and
sex differences. This reveals a critical role of Mllt3 in the maintenance of normal metabolic
homeostasis.

xiv

CHAPTER ONE
BACKGROUND
Mixed Lineage-Leukemia and MLLT3
Mixed lineage leukemia (MLL) is a form of blood cancer that expresses surface markers
of both lymphoid and myeloid lineages52. The MLL gene, located on chromosome 11 band q23,
also known as the lysine-specific methyl transferase 2A gene (KMT2A) , can be involved in
chromosomal translocations that cause MLL leukemia. As a result of these translocations the
amino terminus of MLL is fused in frame with one of many different fusion partners, causing the
expression of a fusion oncoprotein. MLL is a histone methyltransferase specifically for Histone
H3 lysine 4 through its carboxy terminal SET domain53. Upon translocation, the histone
methyltransferase domain is replaced with portions of the fusion partner but can still bind to
most of the same direct gene targets of MLL1. The fusion of MLLT3, also known as AF9, with
MLL is a common fusion resulting in mixed lineage leukemia2,4. The MLL fusion partners AF9
and AF4 make up 30% of MLL rearranged leukemias with acute myeloid leukemia (AML)
phenotypes while these fusions form 66% of acute lymphoblastic leukemia (ALL) phenotypes
(MLL-AF9 and MLL-AF4). The ability of MLLT3 to recruit the SEC to the target genes of MLL
result in abnormal transcriptional activation of those genes. This results in leukemia3,54.
YEATS Domain Proteins
The YEATS (Yaf9, ENL, AF9, Taf14, and Sas5) domains are a conserved family of
acyllysine readers that recognize and bind to histone acyl marks. AF9 and ENL can recognize
many types of histone acylations but display a preference for lysine crotonylation (Kcr).
1

2

An aromatic sandwich pocket is the reader in the YEATS domains and is formed through the
clustering of conserved residues at loops L4 and L6. This pocket can read a variety of acyl chains
because it is contains an open end allowing it to accommodate a variety of chain lengths within
the sandwich pocket2,4.
Structure and Function of MLLT3
MLLT3 is located on chromosome 9 band p22 and affects the transcription of target genes
through its interaction with different multiprotein complexes. MLLT3 has an N-terminal YEATS
domain that that recognizes acetylated and crotonylated histone marks and has a C-terminal
domain ANC1 homology domain (AHD) that interacts with a variety of multiprotein complexes
(Figure 1)55. The YEATS domain contains two monomers that exist as an asymmetric structure
with both containing a β-strand configuration to secure the YEATS dimer4. MLLT3 forms a
similar eight-stranded immunoglobulin (Ig) fold using loops L4 and L6 to connect four β-strands
and make a serine-lined aromatic two-layer β-sandwich pocket that preferentially recognizes and
binds to crotonylated histones on histone H3 at lysine 9, 18, and 272,4.
The C-terminal domain of MLLT3 promotes transcription through the interaction of
AFF1/AFF4, components of the SEC, or the histone H3K79 methyl transferase DOT1L while
transcriptional repression occurs through interaction with BCOR or CBX8 a component of the
Polycomb group (PcG). Through the interaction of a target histone and PAF1, the SEC is
recruited to RNA Polymerase II resulting in active transcription of target genes3,56. The SEC is
recruited to these regions of active promotors through histone acetylation or crotonylation that is
bound by the YEATS domain of MLLT34. MLLT3 interacts with factors of the PcG like CBX8
through the C-terminal domain resulting in inhibition of target gene transcription3,4. MLLT3
preferentially recognizes H3K9 acetylation and crotonylation, compared to H3K18 and H3K27,
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and recruits DOT1L which methylates H3K79 on target genes and causes abnormal
transcriptional activation leading to leukemogenesis4. DOT1L can put up to three methyl groups
onto H3K79 with di- and trimethylation as marks of euchromatin and active transcription of
genes. In addition, DOT1L interacts with the C-terminal domain of RNA Polymerase II through
the phosphorylated Ser2 and/or Ser5 thus recruiting RNAPII to target genes for transcription 5, 57,
58, 59

. The phosphorylation of Ser2 occurs through the cyclin-dependent kinase 9 (CDK9) of

positive transcription elongation factor b (P-TEFb) which is a factor of the DOT1L-containing
AF4-associated complex5.

Figure 1: MLLT3 Protein Structure. MLLT3 protein structure has an N-terminal YEATS
domain and a C-terminal domain (CTD) that binds different multiprotein complexes. Figure
provided by Dr. Zeleznik-Le. Structures from Lie et al, Mol Cell 62:181, 2016 and Kuntimaddi
et al, Cell Reports 11:808, 2015.

MLLT3 and Hematopoietic Stem Cells
MLLT3 functions in hematopoietic stem cell maintenance and controls erythroid and
megakaryocytic progenitors. The Zeleznik-Le and Hemenway labs created conditional knockout
Mllt3 mice and found a long-term hematopoietic stem cell (LT-HSC) defect in these mice
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(unpublished). The Mikkola lab found that enforced expression of MLLT3 in human CD34 stem
cells resulted in more engraftable and multipotent hematopoietic stem cells. Maintenance occurs
through the binding of the MLLT3 N-terminal YEATS domain to the transcription start sites of
hematopoietic stem cell genes, and by controlling transcription factors necessary for stem cell
maintenance. Proliferation of stem cells is not promoted thus stem cells maintain their stemness
as they divide. When the oncogenic MLL fusions binds to start sites, it can induce the
transformation of progenitors to leukemia stem cells6.
MLLT1
MLLT1, also known as ENL, is a close homolog of MLLT3 that is also a common fusion
partner of MLL in Mixed Lineage Leukemia. Translocation occurs between chromosome 11
band q23 and chromosome 19 band p-13.3. MLLT1 functions in a different SEC than MLLT3,
and more favorably binds to H3K27 acetylation compared to H3K9 and H3K184,61,62. The
MLLT1 protein is also involved in hematopoiesis specifically lineage commitment of progenitor
cells7,60.
Histone Reader
The post-translational modifications of histone tails are recognized by histone readers
generating a response based on the type and location of the modification relative to other
elements. Histone readers can display specificity for the particular post-translational
modifications through the interactions of surrounding residues63. These histone modifications
can be placed or removed by the actions of histone writers and erasers, respectively. For
instance, there are histone readers that specifically recognize methyl marks on lysine and
arginine. Lysine can be mono-, di-, or tri-methylated which determines the reader that can bind
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with the corresponding aromatic ring size. Different histone readers have unique ways to
recognize histone marks2.
Crotonylation and Acetylation
Post-translational modifications (PTMs) on histones function in regulating the
accessibility of DNA to replication and transcriptional machinery thus influencing gene
expression63. MLLT3 and MLLT1 display a preference for acetyl and crotonyl PTMs
specifically on histone H3K9, H3K18, and H3K27. An acetyl mark is added by histone
acetyltransferases (HATs) and removed by histone deacetylases (HDACs)64,65. A lysine residue
has a +1 positive charge that is neutralized when an acetyl mark is placed on the amino group
resulting in the negatively charged DNA being less tightly wound around histones. This
diminished interaction results in increased replication and transcription because of the
availability of the DNA to the respective machinery. In addition, these acetyl groups can be
recognized by histone readers, like MLLT3 and MLLT1, that will bind to these modifications
and influence target gene expression. Previous studies have shown that AF9 and H3K18cr and
H3K18ac co-localize within LPS-stimulated cells66. The crotonyl and acetyl marks on H3K18
marked close to 95% of the AF9-associated genes and 5’ transcription start sites of actively
transcribed genes2,4.
Rationale for Current Project: Previous Lab Data
RNA-sequencing was performed from liver tissue of male and female Mllt3 Alb-Cre
mice, aged 13 weeks. Gene Ontology results comparing Mllt3 Alb-Cre knockouts to control mice
identified potentially altered pathways affected by this liver specific Mllt3 knockout and the
genes differentially expressed in the pathways. The top pathways altered in male Mllt3 Alb-Cre
are relevant to hexose metabolism which was not seen in the results for the female mice. Two of
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the top pathways affected by the Mllt3 liver-specific knockout in male mice were hexose and
monosaccharide metabolic processes. The differentially expressed genes overlap in these two
processes and are as follows: Pck1, Rorc, B4galt1, Gclc, Foxa2, Wdtc1, Gck, Onecut1, and Per2
(Figure 2, Table 1).
Previous studies by separate labs have identified B4galt1 and Gclc as direct targets of
MLLT3 in HeLa cells. Gene Ontology results from female Mllt3 Alb-Cre mice as compared to
controls showed fewer genes significantly affected by the liver specific Mllt3 knockout
compared to male mice. Glucan metabolic processes were affected in the female mice by the
knockout and the two genes associated, Irs2 and Per2, were differentially expressed in multiple
processes (Figure 3, Table 1).

Figure 2: Gene Ontology of Male Mllt3;Alb-Cre RNA-Sequencing. Gene Ontology (GO)
results from RNA-sequencing done on male Mllt3;Alb-Cre mice aged 13 weeks, and
corresponding common differentially expressed genes (DEGs) associated with hexose and
monosaccharide metabolism. B4galt1 and Gclc in bold are known MLLT3 targets in HeLa cells.
Zeleznik-Le Lab, unpublished.
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Figure 3: Gene Ontology of Female Mllt3;Alb-Cre RNA-Sequencing. Gene Ontology (GO)
results from RNA-sequencing on female Mllt3;Alb-Cre mice aged 13 weeks, and corresponding
common differentially expressed genes in glucan metabolic processes. Zeleznik-Le Lab,
unpublished.
Table 1: Gene Expression Changes in Male and Female Mice from RNA-Sequencing . The
change in the expression of genes from the RNA-sequencing results in both male and female
Mllt3;Alb-Cre mice. Genes in bold are known MLLT3 targets in HeLa cells.
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Liver Hexose Metabolism
The liver is essential to carbohydrate metabolism and glucose homeostasis as it balances
the storage of glucose as glycogen as well as the breakdown of glycogen and gluconeogenesis
during fasting. Dysregulation of these processes results in high levels of hepatic gluconeogenesis
and abnormal insulin sensitivity among other effects. Glucose diffuses through the glucose
transporter 2 (GLUT2) and enters into the hepatocytes where it is phosphorylated by either
hexokinase or glucokinase (GK) to glucose 6-phosphate (G6P)8,67. GLUT2 is a bidirectional
glucose transporter in the liver allowing glucose to diffuse out of the hepatocytes and into the
bloodstream. From this form, glucose 6-phosphate can enter a multitude of metabolic pathways
depending on the requirements of the body. These pathways include the pentose phosphate or
hexosamine pathway, oxidative phosphorylation, and glycogenesis9,68,69.
Glycogen synthesis begins when phosphotransferase phosphoglucomutase (PGM)-1
initiates the reversible transfer of the phosphate group from the sixth carbon of glucose to the
first carbon resulting in the isomer glucose 1-phosphate70. Another reversible reaction catalyzed
by UDP glucose pyrophosphorylase (UGP) with Mg2+ present converts glucose 1-phosphate and
UTP to UDP-glucose and PPi71. Glycogen is synthesized by the autoglycosylation of UDPglucose by the glycogenin enzyme that functions as a primer for the initial glucose molecules.
UDP-glucose donates glucose to initiate glycogen synthesis or elongate a growing glycogen
branch. The initial short chain of glycogen formed by glycogenin is elongated by glycogen
synthase that transfers the donated glucose from UDP-glucose to the glycogen strand. This
growing strand forms branches that further elongate by the glycogen branching enzyme72.
Glycogen is stored within hepatocytes until glucose is required then it is broken down to glucose
by glycogenolysis and released into the bloodstream9.

9

Glucose 6-phosphate can also be reversibly isomerized to fructose 6-phosphate by the
enzyme glucose 6-phosphate isomerase (GPI)73. Two pathways diverge from fructose 6phosphate, the hexosamine pathway and the glycolytic pathway. The end products of the
hexosamine pathway are uridine 5’-diphosphate (UDP)-N-acetylglucosamine and glutamate.
From fructose 6-phosphate and glutamine, glucosamine 6-phosphate and glutamate are produced
by either glucosamine 6-phosphate synthase or glutamine: fructose 6-phosphate amidotransferase
(GFAT) by shifting the amino group from the glutamine amide to fructose 6-phosphate. The
primary amine of glucosamine 6-phosphate is acetylated by the enzyme glucosamine 6phosphate N-acetyltransferase (GNA1), using the acetyl group from acetyl-CoA, resulting in Nacetylglucosamine 6-phosphate and the free coenzyme A (CoA-SH). The N-acetylglucosamine
6-phosphate is reversibly converted to N-acetylglucosamine 1-phosphate by Nacetylglucosamine-phosphate mutase (AGM1) also known as PGM3. The final reaction to
produce UDP-N-acetylglucosamine is generated by the enzyme UDP-N-acetylglucosamine
pyrophosphorylase (UAP1) or by N-acetylglucosamine 1-phosphate uridyltransferase. In this
reaction, the uridyl group of UTP is relocated to N-acetylglucosamine 1-phosphate resulting in
two remaining phosphate groups. N-acetylglucosamine residues from UDP-N-acetylglucosamine
form glycans fixed to proteins or lipids, by the enzyme UDP-N-acetylglucosamine transferase,
that are precursors for glycosylation. In addition, the hexosamine pathway contains a feedback
loop with the end product inhibiting the formation of glucosamine 6-phosphate9,74.
In the anaerobic glycolytic pathway, glucose goes through three metabolic pathways
resulting in glucose being oxidized to carbon dioxide and the production of energy in the form of
ATP. Glycolysis is the first of these metabolic pathways and occurs anaerobically in the cytosol
of the cell. As previously mentioned, when glucose diffuses into the cell through GLUT2 and is
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phosphorylated to glucose 6-phosphate by glucokinase or hexokinase which transfers a
phosphate from ATP. Glucose 6-phosphate is then isomerized to fructose 6-phosphate by GPI
(phosphoglucose isomerase)73. Fructose 6-phosphate can then go into the hexosamine pathway or
continue through glycolysis where it is phosphorylated by phosphofructokinase (PFK), again
using a phosphate group from ATP, and becomes fructose 1,6-bisphosphate. Fructose 1,6bisphosphate is cleaved into two different triose isomers dihydroxyacetone phosphate (DHAP)
and glyceraldehyde 3-phosphate (GAP) by enzyme aldolase. DHAP is eventually isomerized to
glyceraldehyde 3-phosphate by triosphosphate isomerase resulting in two GAP molecules32.
During the next reaction, a hydrogen molecule is removed from GAP and added to nicotinamide
adenine dinucleotide (NAD+) and another phosphate group is added to molecule making 1,3bisphosphoglycerate by the enzyme glyceraldehyde 3-phosphate dehydrogenase. The next
enzyme phosphoglycerate kinase removes the phosphate group just added to 1,3bisphosphoglycerates and places it on ADP to generate two ATP and two molecules of 3phosphoglycerate. The enzyme phosphoglycerate mutase repositions the phosphate group on 3phosphoglycerate from the third carbon to the second generating two molecules of 2phosphoglycerate. After moving the phosphate, a molecule of water is eliminated from the 2phosphoglycerate by enolase and generating two phosphoenolpyruvates (PEP). The final step of
glycolysis is the removal of the phosphate group off the 2’ carbon PEP and phosphorylating
ADP generating two ATP and two pyruvates by the enzyme pyruvate kinase. Four ATP are
generated during this process with a net gain of two ATP and 2 NADH9,10,32.
The Citric Acid (TCA) cycle and oxidative phosphorylation are the next two metabolic
processes that occur after glycolysis. Unlike glycolysis, these processes are aerobic and occur
within the mitochondria. Pyruvate crosses the outer mitochondrial membrane through the
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voltage-dependent anion channel (VDAC) or porins that are non-selective channels allowing
diffusion of pyruvate75. Transport across the inner mitochondrial membrane into the
mitochondrial matrix is much more restricted and not well understood. Pyruvate is first
converted to acetyl-CoA by the pyruvate dehydrogenase (PDH) complex within the
mitochondrial matrix by irreversibly removing carbon dioxide and reducing NAD+ to
NADH48,75. Acetyl CoA enters the TCA cycle and is combined with oxaloacetate by citrate
synthase releasing CoA from the newly formed citrate. Citrate is subsequently converted to
isocitrate through two reactions with the enzyme aconitase that first dehydrates citrate into cisaconitate and then rehydrated into isocitrate. In the following reaction, isocitrate is converted to
α-ketoglutarate by the enzyme isocitrate dehydrogenase that removes carbon dioxide and results
in the reduction of NAD+. A similar reaction occurs when α-ketoglutarate is transformed into
succinyl-CoA by α-ketoglutarate dehydrogenase. During this reaction, CoA is reintroduced into
the TCA, and carbon dioxide is again removed from the molecule along with the reduction of
NAD+. CoA is quickly removed from the reaction and GTP is generated when succinate is
generated from succinyl-CoA. Succinate is dehydrated by succinate dehydrogenase into fumarate
and FADH2 is produced in the process. Fumarase hydrates fumarate into L-malate which is
dehydrated into oxaloacetate by malate dehydrogenase resulting in the reduction of NAD+ to
NADH. This oxaloacetate will then be combined with a new molecule of acetyl CoA and the
cycle continues9,49,76.
The NADH and FADH2 formed by the series of reactions in both glycolysis and the TCA
are used in oxidative phosphorylation on the electron transport chain (ETC) as electron donors.
The electron transport chain located on the inner mitochondrial membrane is made up of four
complexes and ATP synthase. NADH interacts and donates electrons at complex I of the ETC
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while FADH2 does so at complex II and donates electrons that will travel from complex I to
coenzyme Q also called ubiquinone. Coenzyme Q carries these donated electrons to complex III
where the electrons are transferred to cytochrome c. The electrons are then taken to complex IV
of the ETC by cytochrome c where they are transferred to oxygen molecules. Within the inner
membrane space, the oxygen molecules with the donated electrons interact with free hydrogen
molecules to produce water. As the movement of electrons is occurring, hydrogen molecules are
pumped across the inner membrane of the mitochondria through complexes I, III, and IV and
into the intermembrane space creating a proton gradient77,78,79,80,81,82,83,84. Complex V or ATP
synthase has two components: F0 which traverses the inner membrane allowing hydrogen
molecules to flow down the concentration gradient to the mitochondrial matrix, and the F1
subunit which harvests the energy from the movement of hydrogen and produces ATP. Oxidative
phosphorylation generates 32 to 34 molecules of ATP with each NADH synthesizing three
molecules while FADH2 does two11,50,85,86,87.
Glucose 6-phosphate may also proceed into the pentose phosphate pathway (PPP) or
pentose phosphate shunt rather than other metabolic pathways. The overall result of the pentose
phosphate pathway is the productive of NADPH and ribose 5-phopshate essential for the
formation of nucleic acids. Within hepatocytes, NADPH is critical to produce fatty acids, while
NADPH in red blood cells assists in supporting reduced glutathione which removes antioxidants
from cells. The PPP occurs in the cytosol and consists of the oxidative and non-oxidative
branches. In the oxidative branch, the enzyme glucose 6-phosphate dehydrogenase converts
glucose 6-phosphate from glycolysis to 6-phosphogluconolactone and NADPH that will reduce
oxidized glutathione (GSSG) to reduced glutathione (GSH)88. 6-phosphogluconolactone is
broken down by hydrolysis with the enzyme 6-phosphogluconolactonase (6PGL) to 6-
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phosphogluconate (6PG) which is converted to ribulose 5-phosphate (Ru5P) and produces
NADPH by 6-phosphogluconate dehydrogenase89. The remaining reversible series of reactions
in the pentose phosphate pathway are part of the non-oxidative branch. Ribulose 5-phosphate is
reversibly transformed into ribose 5-phosphate by ribose 5-phosphate epimerase and xylulose 5phosphate (Xu5P) by ribulose 5-phosphate epimerase. The enzyme transketolase (TKT) converts
Xu5P and ribose 5-phosphate to glyceraldehyde 3-phosphate, and transforms Xu5P and erythrose
4-phosphate into glyceraldehyde 3-phosphate and fructose 6-phosphate controlling the flow of
molecules between glycolysis, gluconeogenesis, and the pentose phosphate pathway. The
enzyme transaldolase catalyzes another series of reversible reactions that converts
glyceraldehyde 3-phosphate to erythrose 4-phosphate and sedoheptulose 7-phosphate to fructose
6-phosphate90. Overall, the pentose phosphate pathway plays a role in glucose metabolism by
redirecting glycolysis intermediates into the shunt, and by ultimately controlling the flow of
more downstream glycolytic or gluconeogenic molecules back into the respective pathways12.
In addition to breaking down glucose, the liver is also able to produce glucose by
gluconeogenesis and glycogenolysis. Gluconeogenic precursors like lactate, alanine, and glycerol
are used to synthesize de novo glucose molecules through gluconeogenesis by entering different
parts of that pathway depending on structure of the precursor. For instance, lactate is reversibly
converted to pyruvate by the enzyme lactate dehydrogenase (LDH) and also generates reduced
NAD+ to NADH. L-alanine is also transformed into pyruvate but by the enzyme alanine
aminotransferase (ALT). α-oxoglutarate is converted by glutamate pyruvate transaminase to Lglutamate which can be quickly transformed to α-ketoglutarate by the enzymes glutamate
dehydrogenase, glutamate-oxaloacetate aminotransferase, and glutamate-pyruvate
aminotransferase9,13. An abundancy of acetyl-CoA stimulates the irreversible carboxylation of
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pyruvate to oxaloacetate, another molecule in the Citric Acid Cycle, by pyruvate carboxylase.
From oxaloacetate, phosphoenolpyruvate (PEP), an intermediate of glycolysis, is irreversibly
formed in the cytosol by the critical enzyme phosphoenolpyruvate carboxykinase (PEPCK). The
remainder of gluconeogenesis occurs within the cytosol and is the reverse of glycolysis from
phosphoenolpyruvate to glucose 6-phosphate. It is important to note that the dephosphorylation
of fructose 1,6-bisphosphate to fructose 6-phosphate by fructose 1,6-bisphosphatase is another
critical part of this pathway51. In comparison, blood glucose levels increase in glycogenolysis
when glycogen is degraded within the cytosol of hepatocytes by the enzymes glycogen
phosphorylase and the glycogen debranching enzyme. Glycogen phosphorylase cleaves the α-1,4
glycosidic bonds using inorganic phosphate resulting in free glucose 1-phosphate which is
quickly transformed into glucose 6-phosphate by phosphoglucomutase. Once the original
glycogen is broken down to the end of a branch point, the glycogen debranching enzyme creates
a new α-1,4 glycosidic bond by moving one branch to a new glycogen chain. This movement
leaves a glucose residue behind that is freed by α-1,6-glucosidase14,91. In order for glucose 6phosphate to be converted to glucose, the glucose 6-phosphate translocase transfers the molecule
into the endoplasmic reticulum where it is dephosphorylates by glucose-6-phosphatase9,92.
Hexose Metabolism Genes Differentially Expressed Following Mllt3 Knockout from RNASequencing Analysis
Phosphoenolpyruvate Carboxykinase
Phosphoenolpyruvate Carboxykinase (Pck1/PEPCK) is the enzyme that catalyzed the
initial rate-limiting reaction of gluconeogenesis where oxaloacetate is converted to
phosphoenolpyruvate in the cytoplasm of the cell. Expression of Pck1 is controlled by multiple
different factors and hormones and specifically can be activated by glucocorticoids and cyclic
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AMP and inhibited by insulin in the liver. In addition, Pck1 expression is directly correlated with
blood glucose concentration within the liver and kidneys. The heterodimer PPARγ/RXRα has
been known to regulate Pck1 expression (Figure 4)15,16.
RAR Related Orphan Receptor C
RAR Related Orphan Receptor C (Rorc), also known as Rorγ, is involved in the
regulation of hepatic glycolysis and gluconeogenesis. Previous studies have found that the loss of
Rorc reduced expression of genes associated with glucose metabolism and hepatic glucose
production resulting in lower gluconeogenesis and glycolysis. Rorc has been found to promote
Pck1/PEPCK in gluconeogenesis and the gene Gck in glycolysis (Figure 4)17,18,19.
Beta-1,4-Galactosyltransferase
Beta-1,4-Galactosyltransferase (B4galt1) is the gene encoding a type II membrane bound
glycosyltransferase glycoprotein that catalyzes the transfer of galactose to the Nacetylglucosamine (GlcNAc) on N-glycans of carbohydrates in the Golgi Apparatus.
Additionally, B4galt1 is involved in lactose synthesis in the mammary gland by forming the
lactose synthase complex through dimerization with α-lactAlbumin20,21.
Glutamate-Cysteine Ligase Catalytic Subunit
The Glutamate-Cysteine Ligase Catalytic Subunit (Gclc) encodes the catalytic subunit of
the heterodimer rate-limiting enzyme for glutathione synthesis, Glutamate Cysteine Ligase,
where glutamate and cysteine are linked. The Citric Acid Cycle can be a source of glutamate
from the intermediate α-Ketoglutarate. Glutathione (GSH) is an antioxidant that removes free
radicals and reactive oxygen species and is oxidized to glutathione disulfide (GSSG) by these
substances. NADPH-dependent glutathione reductase reduces GSSG back to GSH. The Pentose
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Phosphate Pathway is one source of NADPH. The liver is also the main producer and exporter of
glutathione in the body (Figure 4)22,23.
Forkhead Box A2
Forkhead Box A2 (Foxa2) functions in lipid and glucose metabolism and homeostasis
through the regulation of gene expression in response to insulin. For instance, Foxa2 functions in
suppressing of hexokinase expression and regulating glucokinase expression. These enzymes are
involved in the preliminary step of glycolysis, and high hexokinase activity has also been linked
to increased insulin secretion. Additionally, Foxa2 interacts with genes for β-oxidation of fatty
acids. This breakdown of fatty acids can result in the production of Acetyl Co-A that is used in
The Citric Acid Cycle (Figure 4)24,25,26,27.
WD and Tetratricopeptide Repeats 1
WD and Tetratricopeptide Repeats 1 (Wdtc1) is an anti-obesity gene where its expression
inhibits lipid accumulation and obesity and enhances glucose tolerance in mice. In the context of
hexose metabolism, Wdtc1 inhibits PPAR-γ which normally forms a heterodimer with RXRα and
promotes Pck1/PEPCK expression for the first critical step in gluconeogenesis (Figure
4)28,29,30,31.
Glucokinase
Glucokinase (Gck) is one of the two enzymes in the first step of glycolysis where glucose
irreversibly phosphorylated to glucose-6-phosphate. The other gene for this step, hexokinase,
functions similarly, but is inhibited by high levels of glucose-6-phosphate its own product. Since
hexokinase is inhibited by its product, when blood glucose is high, glucokinase is the main
phosphorylator of glucose. Glucokinase can be inhibited by the isomer of glucose-6-phosphate
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fructose-6-phosphate by its binding. Fructose-1-phosphate reverses this inhibition by breaking
down the glucokinase-regulatory protein complex (Figure 4)32,33,34.
One Cut Homeobox 1
The gene One Cut Homeobox 1 (Onecut1), also called HNF-6, encodes transcription
factors that are enriched within the liver. The encoded factors in the liver function in the control
of genes associated with glucose metabolism like Pck1, Glucose-6-Phosphatase, and
Glucokinase. Onecut1 binds specifically to the hepatic Glucokinase promoter and regulates the
expression without the influence of insulin. Additionally, Onecut1 inhibits the activity of Pck1 in
gluconeogenesis (Figure 4)35,36.
Period Circadian Regulator 2
Period Circadian Regulator 2 (Per2) inhibits the transcriptional activity of PPAR-γ
which affects the formation of the heterodimer with RXRα and subsequently genes associated
with adipogenesis and the expression of the gene Pck1. Per2 is part of the Period gene family
that are associated with the circadian rhythms of a variety of bodily functions like metabolism
(Figure 4)37,38.
Insulin Receptor Substrate 2
Insulin Receptor Substrate 2 (Irs2) function in insulin signaling through tyrosine
phosphorylation of the substrate. Irs2 specifically functions in nutrient homeostasis and the
PI3K-Akt cascade in hepatocytes by insulin and is regulated by feedback loops. Irs2 also
represses gluconeogenesis and apoptosis in hepatocytes. Additionally, Irs2 regulates glucokinase
expression and glycolysis (Figure 4)39.
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Figure 4: RNA-Sequencing Genes in Hexose Metabolism. Genes identified by RNAsequencing data and how they function in hexose metabolism in the liver. The color of gene
names indicate how expression was changed within the Mllt3;Alb-Cre knockouts. Green
indicates an increase while red is decrease.
Sex-Related Differences in Liver Biology and Gene Expression
It has been well established that there are sex specific differences in many aspects of the
liver. As reviewed in “Mitochondrial Roles and Cytoprotection in Chronic Liver Injury”, the
expression of genes varies between sexes which affects downstream processes like drug
metabolism, hormone levels, and reproduction. Males and females also show differences in what
types of liver injuries and diseases are more likely to develop. Acute liver failure, biliary
cirrhosis, and benign liver tumors are more common in females while malignant liver tumors and
viral hepatitis are more common in male patients. Importantly, death from chronic liver disease
and cirrhosis is more prevalent in men. Females present more severe liver injury possibly
occurring from the concentrations of estrogen receptors in Kupffer cells that cause inflammation
and necrosis and increased endotoxin levels40,93. Additionally, the levels of estrogen may be
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associated with benign liver tumors found more commonly in females, and directly regulates
genes related to fatty acid uptake, oxidation, and cholesterol absorption46. Estrogen has also been
linked to nonalcoholic fatty liver disease since it is more common in men and in postmenopausal women40,94. Additionally, many genes associated with liver development and
function have been shown to be differentially regulated and expressed between sexes. Variations
in the expression of sex-related genes were identified in the livers47. These variations led us to
study sex related differences in our own work.
Mitochondria Function
The liver contains a high quantity of mitochondria that function in energy production by
oxidative phosphorylation as well as controlling the initiation of apoptosis by the mitochondrial
membrane permeabilization (MMP)95. Liver mitochondria are critical to metabolic homeostasis
of carbohydrates, lipids, and proteins. The metabolism of glucose begins with glycolysis in the
cytoplasm and progresses into the citric acid cycle when pyruvate, the final product of
glycolysis, is converted to acetyl-CoA by the pyruvate dehydrogenase complex within the
mitochondrial matrix. One of the major sources of ATP, oxidative phosphorylation, occurs
within the mitochondria on the inner mitochondrial membrane. It is also a source of reactive
oxygen species (ROS) if electrons from complexes I, III, and IV reduce oxygen early forming
superoxide radicals41,96,97,98. The mitochondrial enzymes SOD2 and MnSOD transform these
superoxide radicals into hydrogen peroxide which is detoxified by glutathione peroxidase99.
Mitochondria also contribute to lipid metabolism through the expression of carnitine palmityl
transfers on both mitochondrial membranes allowing acyl-CoA transport and entry into the βoxidation process to break down fatty acids. De novo lipogenesis is also influenced by the citrate
transport protein located on the mitochondria allowing acetyl-CoA to enter the cytoplasm instead
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of proceeding through the citric acid cycle and act as a precursor for forming lipids41,100. Liver
mitochondria are also critical to protein metabolism through the urea cycle which detoxifies
ammonia. Before the rate-limiting enzyme of the urea cycle carbamoyl phosphate synthetase
(CPS I) can function, it is first activated by N-acetyl-glutamate (NAG). NAG is generated by the
enzyme NAG synthase from the condensing glutamate and acetyl-CoA and promoted by the
presence of arginine101. The urea cycle begins in hepatocyte mitochondria with activated CPS I
combining bicarbonate and ammonia from urea into carbamoyl phosphate. Ornithine
transcarbamoylase (OTC) condenses the carbamoyl phosphate and ornithine to produce citrulline
that leaves the hepatocyte mitochondria and enters the cytoplasm by ornithine translocase. In the
cytoplasm, citrulline interacts with aspartate to form argininosuccinate by the enzyme
argininosuccinate synthetase and uses ATP. An argininosuccinate lyase cleaves
argininosuccinate into arginine and fumarate, a citric acid cycle intermediate. The final step of
the urea cycle involves the hydrolysis of arginine by arginase resulting in ornithine and urea that
will be excreted through the kidneys42.
Mitochondria also crucially function in controlling cell survival or death through the
management of mitochondrial membrane permeability of the outer and inner membrane. Proand anti-apoptotic Bcl-2 family members affect the mitochondrial membrane permeability by
either promoting the permeability (pro-apoptotic) or inhibiting the permeability (anti-apoptotic).
Mitochondrial membrane potential of both the outer and inner membrane is also influenced by
other factors like pH and reactive oxygen species102. Apoptosis is initiated by two different
pathways: the extrinsic pathway with activation from death receptors or the mitochondria
intrinsic pathway. When pro-apoptotic factors induce outer membrane permeability, cytochrome
c and other intermembrane space proteins are released from the mitochondria and into the
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cytosol and activate a caspase cascade. Cytochrome c binds to and induces structural changes in
APAF-1 resulting in the formation of an apoptosome which activates caspase-9 from its inactive
form. Active caspase-9 will then also trigger executioner caspases-3 and -7 resulting in cell
death. SMAC/Diablo and Omi/HtrA2 also trigger caspases by hindering XIAP, the inhibitor of
caspases, resulting in apoptosis41,43,103.
Based on Gene Ontology results from RNA-Sequencing and how Mllt3 controls
transcription of target genes, I hypothesize that Mllt3 regulates hexose and monosaccharide
metabolic processes and mitochondrial function within the liver.

CHAPTER TWO
METHODS
RNA Isolation and Quantification
Mouse livers were harvested, cut into small sections, and snap frozen in dry ice before
being stored at -80℃. To extract RNA, approximately 50mg of liver tissue was cut from the
frozen liver sections using a razor blade. This tissue was then placed in a dounce homogenizer
containing 1mL of TRIzol Reagent (Sigma) and homogenized 20 passes with pestle A. The
lysate was transferred to a new 1.5mL microcentrifuge tube and incubated for 5 minutes at room
temperature. 200uL of chloroform was added to the lysate and the tube was inverted followed by
a 15-minute incubation again at room temperature. The tubes were then centrifuged at 12,000 x g
for 15 minutes at 4℃. The aqueous phase was transferred to a new 1.5mL microcentrifuge tube
while the interphase and organic phase were saved for liver DNA extraction. 500uL of
isopropanol was added to the aqueous phase and the tube was inverted to precipitate the RNA. It
was then incubated at room temperature for 10 minutes followed by centrifugation at 12,000 x g
for 10 minutes at 4℃. The supernatant was removed, and the RNA was washed with 1mL of
75% ethanol and vortexed. The tubes were centrifuged at 7,500 x g for 5 minutes at 4℃. The
supernatant was again removed, and the ethanol wash was repeated. The final RNA pellet was
air dried for around 5 minutes at room temperature and then resuspended in 30μL of nuclease
free water. After the RNA was in solution, it was NanoDropped using the Thermo Scientific
Nanodrop 2000c Spectrophotometer. RNA concentration was measured in ng/μL andthe 260/280
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ratio was also documented and should be between 1.8 and 2.0. After being NanoDropped, the
tubes were snap frozen and stored at -80℃.
cDNA Synthesis
The previously isolated and NanoDropped RNA was diluted in water to 2ug or a
maximum of 10uL of RNA for the reaction. The entire 10μL dilution was used in each reaction.
A cDNA master mix was created with 2μL 10x RT Buffer(Applied Biosystems High Capacity
cDNA Reverse Transcription Kit), 0.8μL 25x DNTPs (Applied Biosystems), 2μL 10x Primers
(Applied Biosystems), 1μL Reverse Transcriptase (Applied Biosystems MultiScribe Reverse
Transcriptase), and 4.2μL water per reaction. The final volume for each reaction was 20μL with
10uL from the master mix and the remaining 10uL from the diluted RNA. The tubes were
vortexed and placed in the Bio-Rad thermocycler using the following run cycle: 25℃ for 10
minutes, 37℃ for 2 hours, 85℃ for 5 minutes, and hold at 4℃. After the reaction was finished,
the cDNA was snap frozen and stored at -20℃.
Real-Time Quantitative Reverse Transcription PCR
A master mix was created for each gene of interest with specific Taqman Primer/Probes
(Table 2). 10μL 2x ABI mix (Applied Biosystem TaqMan™ Fast Advanced Master Mix REF
4444557), 1μL of 20x of a Taqman Primer/Probe, 1μL of Polr2a Taqman Primer/Probe is used
to normalize expression in gene expression analysis, 1μL of cDNA, and 8μL of water per
reaction. The master mix was made without cDNA and divided into different microcentrifuge
tubes with the volume required for triplicate reactions of each cDNA sample. cDNA was added
to the individual master mixes and 20μL of each master mix was added to individual wells in a
96 fast well plate (PR1MA MIDSCI™ Lot No: 21052). A film was placed over a plate (Excel
Scientific, Inc. ThermalSeal RTS™ Lot #: OH309G) and it was placed into the Quantstudio 6
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Flex machine (Applied Biosystem). On the QuantStudio Real-Time PCR Software the setup was:
QuantStudio™ 6 Flex System, Fast 96-Well (0.1mL), Comparative CT (ΔΔCT), Taqman ®
Reagents, and Fast 96 well. The genes of interest were had FAM reporters while Polr2a was VIC
meaning if done in duplex the two probes would have different colored reporter dye so they
could be distinguished from one another.. The cycling conditions were as follows: a hold stage
was 50℃, an additional hold stage of 95℃ for 20 seconds, and the PCR stage was 95℃ for 1
second followed by 60℃ for 20 seconds for 40 cycles. 2- ΔΔCT analysis was done on the genes of
interest and the housekeeping gene Polr2a by calculating the difference between the expression
levels.
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Table 2: Taqman Primer Probes for Real-Time Quantitative Reverse Transcription PCR.
Taqman Primer, species, forward and reverse primer, and probe for each gene studied by qRTPCR. All sequences are indicated in the 5’ to 3’ orientation. FAM is the 5’fluorescent reporter
dye and IABkFQ (Iowa Black FQ) is the 3’ quencher.
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Liver DNA Isolation
500μL of Back Extraction Buffer (BEB, 4M Guanidine Thiocyanate, 50mM Sodium
Citrate, and 1M Tris Base), was added to the saved interphase and organic phase from the initial
steps of RNA isolation and extracts the DNA. The tube was inverted to mix and incubated at
room temperature for 10 minutes then centrifuged at 3,000 x g for 30 minutes at 4℃. The upper
phase was transferred to a new 1.5mL microcentrifuge tube leaving the interphase behind. 4uL of
polyacryl carrier (Molecular Research Center, Inc. Cat. No.: PC 152) and 400μL of isopropanol
were added to the DNA that was inverted and incubated again at room temperature for 5
minutes. The tubes were then centrifuged at 12,000 x g for 5 minutes at 4℃. The supernatant
was removed, and the remaining pellet was washed with 1mL of 75% ethanol and incubated for
5 minutes at room temperature. The tubes were again centrifuged at 12,000 x g for 5 minutes at
4℃ and the supernatant was removed afterwards. The 75% ethanol wash was repeated an
additional two times for three washes total. The DNA pellet was air dried for 5 minutes at room
temperature and resuspended in 100μL TE. The DNA was incubated at 60℃ for 5 minutes and
stored at 4℃ once in solution.
Quantitative DNA PCR
A master mix was with 10μL of 2x SYBR Green (BIO RAD SsoAdvanced Universal
SYBR® Green Supermix Cat#1725271), 0.65μL 10μM of the forward, 0.65μL of 10μM of the
reverse primers for either the mitochondrial DNA ActB or genomic DNA CytB (Table 3), and
7.7μL of water per reaction. The master mix was made without cDNA and split into new
microcentrifuge tubes with enough volume for a triplicate or pentaplicate reaction for each
sample. cDNA was added to the master mixes and 20μL of the reaction was loaded into each
well of a 96 fast well plate (PR1MA MIDSCI™ Lot No: 21052). A protective film was put over
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the plate and loaded into the Quantstudio 6 Flex machine (Applied Biosystem). The setup of the
QuantStudio Real-Time PCR Software was: QuantStudio™ 6 Flex System, Fast 96-Well
(0.1mL), Comparative CT (ΔΔCT), SYBR® Green Reagents, and Fast 96 well. The reaction
conditions were: hold stage at 98℃ for 2 minutes, a PCR stage with 40 cycles first at 98℃ for 5
seconds then at 60℃ for 20 seconds, and a melt curve stage for 1 minute at 60℃ then for 15
seconds at 98℃. A melt curve was generated for these reactions which should show a single
peak from the pentaplicate reactions. More than one peak may indicate some error in the setup of
the experiment or non-optimal PCR conditions for amplification. 2- ΔΔCT analysis was used to
calculate relative mitochondrial DNA gene quantity (CytB) or mitochondrial quantity relative to
the quantity of the nuclear ActB gene DNA (Table 3).
Table 3: Sequence of ActB and CytB Primers for Quantitative DNA qPCR. The ActB primer
for nuclear DNA and the CytB primer for mitochondrial DNA to quantify mitochondrial DNA
quantity compared to nuclear DNA.
Gene Species
Forward
Reverse
ActB

Mus

5’

5’

musculus CGGCTTGCGGGTGTTAAAAG CTTCATGTCGGACGAGGCTTA

CytB

Mus
musculus

3’

3’

5’

5’

CGTGATCGTAGCGTCTGGTT

TGTGGCTATGACTGCGAACA

3’

3’

Mitochondrial Enrichment
Mice were sacrificed the day of the Seahorse experiment, and their livers were harvested.
Between 0.4g and 0.5g of the large lobe was cut and placed into a well of a 6 well plate
containing 5mL of MHSE+BSA (70mM Sucrose, 210mM Mannitol, 5mM Hepes, 1mM EGTA,
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0.5% (w/v) fatty acid free Bovine Serum Albumin (Sigma Aldrich Lot # SLBZ3340), pH 7.2).
The following manipulations were performed on ice. The liver section was cut into small pieces
using scissors and was then transferred to a 15mL conical tube by a 10mL pipet. The same 10mL
pipet was used to remove the supernatant from the tissue. To rinse the tissue, 5mL of new
MHSE+BSA was added to the tissue, the tube was vortexed, and the supernatant was again
removed. The rinse was repeated and after the final rinse, the tissue was in new MHSE+BSA.
2mL of tissue and MHSE+BSA was pipetted into a chilled dounce homogenizer using a 10mL
pipet. 10 strokes of pestle A and 40 strokes of pestle B homogenized the liver tissue which was
then decanted into a chilled 2mL microcentrifuge tube and placed on ice. The tubes were
centrifuged at 800 x g for 10 minutes at 4℃. The fat layer was vacuum aspirated from the
supernatant and the lysate was transferred to a new 2mL microcentrifuge tube. The tubes were
centrifuged at 8,000 x g for 10 minutes at 4℃ and the layer of fat and supernatant were removed
using a vacuum aspirator. The pellet was then resuspended in 1mL of MAS1X without
supplements (70mM Sucrose, 220mM Mannitol, 10mM KH2PO4, 5mM MgCl2, 2mM Hepes,
1mM EGTA, 2mM DL-Malic acid, pH 7.2). Following quantification (Coomassie Protein Assay
below), equivalent protein amounts of the enriched mitochondria preparations were immediately
used for the Seahorse functional assay (below).
Coomassie Protein Assay
A Thermo Fisher Scientific Coomassie Protein Assay (REF: 23238) was performed on
the enriched mitochondrial samples. Bovine Serum Albumin (BSA, Sigma Aldrich Lot #
SLBZ3340) was diluted to make the standards concentrations (μg/mL) of: 2000, 1500, 1000,
750, 500, 250, 125 and 25. The 10mg/mL BSA stock was diluted 1:5 with 200μL of stock BSA
and 800μL MAS1X without supplements. Standards were created as outlined in Table 4. The
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blanks for this assay contained 10μL of MAS1X without supplements and each of the samples
were 7μL of MAS1X without supplements and 3μL of enriched mitochondria. The standards,
blanks, and samples were all run in triplicate reactions and 10μL of each was loaded into
individual wells of a 96 well plate. 300μL of Coomassie Plus-The Better Bradford Assay™
Reagent (Thermo Scientific REF: 23238) was added to each well and incubated at room
temperature for 10 minutes before being loaded into the BioTek Microplate Reader (BiotTek
Synergy H1 microplate reader). The plate was read at 595nm and a standard curve was generated
from the concentrations of the standards.
Table 4: Bovine Serum Albumin Standards for the Coomassie Protein Assay. The volumes
of MAS1X without supplements and the source and volume of BSA to create each standard for
the Coomassie protein assay.
Standard Volume of
Volume of
BSA
MAS1X w/o BSA (μL)
Standard
Supplements
Concentration
(μL)
(μg/mL)
A
0
300 of
2000
Stock
B
125
375 of A
1500
C

325

325 of A

1000

D

175

175 of B

750

E

325

325 of C

500

F

325

325 of E

250

G

325

325 of F

125

H

400

100 of G

25

Western Blot
25μL samples from mitochondria enrichment were pipetted into 1.5mL microcentrifuge
tubes containing 5x SDS loading buffer and mixed. These tubes were snap frozen and stored at 80℃ until use. To perform the western blot, the samples were thawed and incubated at 95 ℃ for
5 minutes on a heat block. The samples were cooled to room temperature and briefly centrifuged.
The day before, a 10mL 12% SDS-PAGE gel (4.34mL dH2O, 3mL 40% Acrylamide, 2.5mL 1.5
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M Tris pH 8.8, 100μL 10% SDS, 50μL 10% APS, 10μL TEMED (FisherBiotech Lot # 991412))
was made with a 5mL 4% stacking gel (3.8mL dH2O, 0.5mL 40% Acrylamide, 0.625mL 1M
Tris pH 6.8, 50μL 10% SDS, 25μL 10% APS, 5μL TEMED (FisherBiotech Lot # 991412)). The
samples were loaded onto the gel and electrophoresed at 190V in 1X Running Buffer (200mL
5X transfer buffer, 600mL nanopure water, 200mL ethanol; Tran-Blot Turbo RTA Transfer Kit,
LF PVDF Cat# 1704274) for around 50 minutes or until the 5X SDS dye reached the end of the
gel. The proteins were then transferred to a PVDF membrane (BioRad TransBlot Turbo RTA
Transfer Kit PVDF Cat# 1704274) with the BioRad Transblot Turbo Semi-Dry Transfer Unit
(Biorad Trans-Blot Turbo Transfer System) at 2.5A constant, 25V for 15 minutes. The
membranes were rinsed with TBST (50mM Tris, 150mM NaCl, 0.2%, pH 7.5) and then blocked
for 1 hour in TBST and 5% (w/v) nonfat dry milk on a belly dancer at room temperature. The
membranes were then incubated overnight at 4℃ on an orbital shaker with the Mitochondrial
Fraction Cocktail (Abcam #ab139416 Mouse IgG) that was diluted 1:250 in 5mL of blocking
buffer (20μL of the antibody in 5mL of TBST with 5% milk). The following day, the membrane
was rinsed with TBST and washed three times with TBST on a horizontal rocker for ten minutes
each rinse. The membrane was then incubated with Mouse IgG-HRP (GE Healthcare #NA931)
that was diluted 1:5000 in 6mL of blocking buffer (1.2μL Mouse IgG-HRP in 6mL TBST with
5% milk). The membrane was then incubated on a horizontal rocker at room temperature for 1.5
hours. The membrane was again rinsed with TBST and washed three times with TBST on a
horizontal rocker for 10 minutes each rinse. Using the WesternBright Quantum ECL Kit
(Advansta cat#K-12042-C20) the membrane was incubated for 2 minutes with 400μL of
WesternBright Peroxide and Western Bright Quantum that were mixed and pipetted directly on
the membrane making sure the entire membrane was covered. After the two minutes, the
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remaining ECL was removed and the membrane was wrapped in saranwrap and placed in the
iBright Imager (invitrogen by Thermo Fisher Scientific iBrightCL1000) to visualize.
Image J was used to normalize the western blot data from enriched mitochondria between
Seahorse pairs by first quantifying pixels and then comparing to the concentration of
mitochondria loaded in the western blot. A mathematical formula between the samples allowed
for the results of Seahorse Assays to be adjusted based on mitochondrial enrichment.
Seahorse Assay
The enriched mitochondria were pelleted again by centrifuging 8,000 x g for 10 minutes
at 4℃ and then resuspended in MAS1X with BSA and sodium pyruvate (0.2% (w/v) fatty acid
free BSA and 10mM Sodium Pyruvate). 10μg, 16.67μg, and 23.33μg of protein per well were
loaded onto a Seahorse Assay XF96 Cell Culture Microplate (Agilent Technologies). The
amount of enriched mitochondria to use was established from the concentrations determined by
Coomassie assay, so equal amounts would be used from each sample. The remaining volume
was made of MAS1x with BSA and sodium pyruvate (MAS1X with supplements) with the final
volume being enough for 5 replicates of each sample and protein amount. Master mixes were
made for each sample and protein concentration. 25μL from each master mix was plated per well
on ice while the blanks received only 25μL of MAS1X with BSA and sodium pyruvate. The
plate was then centrifuged at 2,000 x g for 20 minutes at 4℃ and the MAS1X with BSA and
sodium pyruvate was being warmed to 37℃. After centrifugation, 155μL of the MAX with
supplements was added to each well and the plate was placed into the Agilent Seahorse
XFe/XF96 Analyzer (Agilent Technologies). The remaining enriched mitochondria were snap
frozen and stored at -80℃. During the assay, 20μL of 20mM ADP was injected at approximately
9 minutes, 22μL of 20μg/mL Oligomycin at approximately 18 minutes,25μL 40μM FCCP at 28

32

minutes, and 27μL of 5μM Rotenone and Antimycin A at 38 minutes. The change in the oxygen
consumption rate (OCR) over time was measured first at baseline and then after the drugs and
reagents were injected into each well of the cartridge

CHAPTER THREE
RESULTS
Determine the Role of Hepatic Mllt3 Knockout on the Expression of Genes Relevant to
Monosaccharide, Hexose, and Glucan Metabolic Processes Within the Liver.
Expression of Genes Relevant to Hexose, Monosaccharide, and Glucan Metabolic Processes
in Mllt3fl/fl;Alb-Cre Mice Livers From Male and Female Mice of Different Ages
To establish there was a strong Mllt3 knockout in the livers of the Mllt3fl/fl;Alb-Cre mice,
qRT-PCR of Mllt3 was performed in duplex with Polr2a, the gene encoding for the RPB1
subunit of RNA Polymerase II. Regardless of age in male mice (5, 10, 13, 21-25, and 53-57
weeks) and in female mice (5, 10, 13, 21, and 53-57 weeks), there was significantly decreased
expression of Mllt3 within the liver tissue compared to the Mllt3fl/fl controls. (Figures 5a,b).
Complete knockout was not seen within the liver because Cre recombinase expression was
driven by the Albumin promoter. Albumin is expressed in hepatocytes, but not in other liver cell
types, so the remaining cells still express Mllt3. Four main cell types compose the liver and are
broken down into parenchymal cells making up 60-80% of the liver and non-parenchymal cells
20-40%. Hepatocytes make up 70% of the cells in the liver (parenchymal cells) that express
albumin. Of the non-parenchymal cells, 50% are liver sinusoidal endothelial cells, 20% Kupffer
cells, and less than 1% are stellate cells activated by albumin44,45. Grouping male and female
mice regardless of age, there is highly significant reduction in Mllt3 expression in both sexes
(90% deletion in males and 85% in females). Male and female mice with Mllt3 knocked out in
the liver, hereafter referred to as Mllt3ΔHep, regardless of age and sex, grouping all Mllt3fl/fl;Alb33
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Cre mice compared to all of the grouped Mllt3fl/fl controls, showed a highly significant decrease
(87.7%) in Mllt3 expression in the liver of the Mllt3fl/fl;Alb-Cre mice (Figures 5c,d).

Figure 5: Mllt3 Knockout in Male and Female Mllt3ΔHep. Mllt3 expression in (a) male and (b)
female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d) regardless of age and sex. N
is the number of mice per group.

I determined Mllt3-dependent expression of multiple genes relevant to hexose,
monosaccharide, and glucan metabolism that had displayed differential expression in our lab’s
RNA-seq dataset following liver-specific Mllt3 knockout. This included: Pck1, Rorc, B4galt1,
Gclc, Foxa2, Wdtc1, Gck, Onecut1, Per2, and Irs2. I performed qRT-PCR on liver RNA isolated
from control Mllt3fl/fl and Mllt3fl/fl;Alb-Cre mice and analyzed the relative expression of these
genes by age and sex differences, by sex regardless of age, and grouped regardless of age and
sex.
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Pck1 qRT-PCR Mllt3ΔCre
The expression of Phosphoenol-pyruvate Carboxykinase 1 (Pck1), showed no significant
change in expression at 5 to 10 weeks of age in male Mllt3ΔHep and achieved significance at 13
weeks. This was followed by a large reduction in expression at 21-25 weeks of age before being
normalized to a similar expression as the control mice. A similar pattern of Pck1 expression was
observed in female Mllt3ΔHep (Figures 6a,b ). When looking at Pck1 expression grouped
regardless of age and also regardless of age and sex (3% increase), there was no significant
difference between the expression of Pck1 within the Mllt3ΔHep mice, both male (5% increase)
and female (0.5% increase), compared to the control counterparts (Figures 6c,d).

Figure 6: Pck1 Expression Changes Were Similar in Male and Female Mllt3ΔHep. Pck1
expression in (a) male and (b) female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d)
regardless of age and sex. N is the number of mice per group.
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Rorc qRT-PCR Mllt3ΔCre
RAR Related Orphan Receptor C (Rorc) expression in male mice was increased in of the
Mllt3fl/fl;Alb-Cre samples: significantly highest at 5 weeks and remained increased until the 53–
57-week range where it was significantly decreased in expression. In comparison, the expression
of Rorc was not significantly changed in female mice until 21 weeks where it was increased in
expression (Figures 7a,b). Male and female Mllt3ΔHep mice, had increased Rorc expression (60%
males vs 32% females) regardless of mouse age, and overall the Mllt3ΔHep mice had increased
expression (48%) of Rorc (Figures 7c,d).

Figure 7: Rorc Expression was Increased in Young Male and Female Mllt3ΔHep Mice but
Reduced at Old Ages. Rorc expression in (a) male and (b) female Mllt3;Alb-Cre mice grouped
by age, (c) just by sex, and (d) regardless of age and sex. N is the number of mice per group.
B4galt1 qRT-PCR Mllt3ΔCre
The gene Beta-1,4-Galactosyltransferase 1 (B4galt1) had a similar expression pattern in
male Mllt3 knockout mice compared to previously mentioned genes where expression is the
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highest at 5 weeks and remains significantly increased until 53-57 weeks where the change in
expression is comparable to expression in control mice (Figure 8a). In female Mllt3ΔHep mice, the
expression of B4galt1 was significantly changed at 10 weeks with a slight decrease in expression
and at 21 weeks where the Mllt3 knockout had increased expression (Figure 8b). When the
expression of B4galt1 was grouped ignoring age related sex differences, male Mllt3ΔHep mice had
significantly increased expression (45.8%) while female mice did not (3.8%). In addition, the
expression of B4galt1 in male Mllt3ΔHep mice had significantly increased expression compared to
female knockout mice (Figure 8c). Regardless of both age and sex, Mllt3ΔHep mice mice had
increased expression (27.6%) of B4galt1 (Figure 8d).

Figure 8:Young Male Mllt3ΔHep Mice Had Increased B4galt1 Expression. B4galt1 expression
in (a) male and (b) female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d) regardless
of age and sex. N is the number of mice per group.
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Gclc qRT-PCR Mllt3ΔCre
Glutamate-Cysteine Ligase Catalytic Subunit (Gclc) was not significantly changed in
Mllt3ΔHep male mice compared to the wildtype controls while female Mllt3ΔHep mice had
increased Gclc expression at 10 weeks and increased expression at the 53–57-week age range
(Figures 9a,b). Female Mllt3 knockout mice had increased expression (20.5%) when grouped
regardless of age while male mice had no difference (3.7%) in expression (Figure 9c). Thus,
when grouped together regardless of age and sex, Mllt3ΔHep mice had slightly increased (11%)
Gclc expression (Figure 9d).

Figure 9: Gclc Expression was Unchanged in Male Mllt3ΔHep Mice . Gclc expression in (a)
male and (b) female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d) regardless of
age and sex. N is the number of mice per group.
Foxa2 qRT-PCR Mllt3ΔCre
Forkhead Box A2 or Foxa2 expression was elevated in expression in male mice again up
until the 53-57-week age range where there was a significant reduction in expression occurring
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(Figure 10a). In comparison, Mllt3ΔHep female mice had a significant increase in Foxa2
expression was at only 5 and 21 weeks while the remaining ages of interest were found to have
insignificant changes (Figure 10b). Overall, looking at expression differences of Foxa2
dependent on sex, Mllt3ΔHep male and female mice had increased (63.3% males, 22.5% females)
Foxa2 expression (Figure 10c). Thus, regardless of both age and sex, Foxa2 expression was
found to be increased (48.5%) upon knockout of Mllt3 in the liver (Figure 10d).

Figure 10: Foxa2 Expression was Increased in Young Male and Female Mllt3ΔHep. Foxa2
expression in (a) male and (b) female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d)
regardless of age and sex. N is the number of mice per group.
Wdtc1 qRT-PCR Mllt3ΔCre
The gene WD and Tetratricopeptide Repeats 1 (Wdtc1) only had significantly increased
expression when male Mllt3ΔHep mice were older starting at 21-25 weeks and continuing to the
53-57 week age range (Figure 11a). The expression of Wdtc1 in female Mllt3 knockout mice was
considerably more varied starting with an increase in expression at 5 weeks then an increase at
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13 weeks followed by another decrease and then increase at 21 and 53-57 weeks, respectively
(Figure 11b). When grouped only by sex, male and female Mllt3ΔHep mice had a slight significant
increase in expression (14.3% males, 17.4% females) of Wdtc1 (Figure 11c). Comparing the
expression of Wdtc1 as Mllt3ΔHep mice versus control mice, it was found to be increased (15.7%)
when Mllt3 is knocked out in hepatocytes (Figure 11d).

Figure 11: Increased Wdtc1 Expression in Male and Female Mllt3ΔHep by Sex Wdtc1
expression in (a) male and (b) female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d)
regardless of age and sex. N is the number of mice per group.
Gck qRT-PCR Mllt3ΔCre
The expression of glucokinase (Gck) in male mice followed a similar pattern compared to
other studied genes where expression was the highest in the Mllt3ΔHep mice at 5 weeks and
maintained the significant increase until 21-25 weeks where the expression was like that of the
control (Figure 12a). Female Mllt3ΔHep mice displayed a high variability in Gck expression across
the studied age ranges with an insignificant increase first at 5 weeks followed by a significant
decrease in expression at 10 weeks. Expression was increased again by 13 weeks and retained
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until 53-57 weeks where it was no longer significant (Figure 12b). Grouped regardless of age,
only male Mllt3 knockout mice had increased Gck expression (73.6%), with the male knockout
having significantly higher expression than the female knockout (20.8%) (Figure 12c). Similarly,
grouped regardless of age and sex mice with Mllt3 knocked out in their liver had higher
expression (50.8%) of Gck when compared to control mice (Figure 12d).

Figure 12: Increased Gck Expression in Male and Female Mllt3ΔHep. Gck expression in (a)
male and (b) female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d) regardless of
age and sex. N is the number of mice per group.
Onecut1 qRT-PCR Mllt3ΔCre
The gene One Cut Homeobox 1 (Onecut1) is increased in expression in male Mllt3ΔHep
mice from 5 weeks until the 21–25-week age range where it decreases sharply at the 53–57-week
age range. Within the female mice, the expression levels of Onecut1 varies depending on the age
of the knockout mice. Insignificant increases in expression were seen at 5 and 10 weeks,
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followed by a significant decrease in Onecut1 expression at 13 weeks, and another increase in
expression at 21 weeks. At the 53–57-week age range, the expression of Onecut1 in the female
Mllt3ΔHep mice was not significantly different than the matched controls (Figures 13a,b ).
Grouped regardless of age, only male Mllt3ΔHep mice had increased Onecut1 expression (207%
males vs 39.6% females). The male knockout mice had significantly higher expression than the
female knockout mice. In addition, when grouped regardless of age and sex, Onecut1 expression
was significantly increased (134.7%) in expression in the Mllt3ΔHep mice (Figures 13c,d).

Figure 13: Onecut1 Expression Increased in Young Male and Female Mllt3ΔHep. Onecut1
expression in (a) male and (b) female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d)
regardless of age and sex. N is the number of mice per group.
Per2 qRT-PCR Mllt3ΔCre
The expression of Period Circadian Regulator 2 (Per2) was highly upregulated in both
male and female Mllt3ΔHep mice across all age groups, and so when grouped regardless of age,
both sexes had increased Per2 expression(366% males vs 244% females). Thus grouped
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regardless of both age and sex, there was increased Per2 expression (311%) in the liver of mice
when Mllt3 was knocked out (Figures 14a-d).

Figure 14: Per2 Expression Increased at All Ages in Male and Female Mllt3ΔHep. Per2
expression in (a) male and (b) female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d)
regardless of age and sex. N is the number of mice per group.
Irs2 qRT-PCR Mllt3ΔCre
Insulin Receptor Substrate 2 (Irs2) had increased expression in male Mllt3ΔHep mice at 10
and 13 weeks, but was reduced at 21-25 weeks before normalizing out (Figure 15a). In
comparison, female Mllt3ΔHep mice trended towards increased expression at 5 weeks that greatly
decreased by 10 and 13 weeks, but was then normalized at the later time points (Figure 15b).
Irs2 expression grouped by sex (11.3% males vs 11.8% females) and just by genotype (11.5%)
was not significantly changed in Mllt3ΔHep mice compared to controls (Figures 15c,d).
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Figure 15: Irs2 Differences in Expression Between Male and Female Mllt3ΔHep. Irs2
expression in (a) male and (b) female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d)
regardless of age and sex. N is the number of mice per group.
Mllt1 qRT-PCR Mllt3ΔCre
Finally, the close homolog of Mllt3, Mllt1, showed increased expression in Mllt3ΔHep
male mice up until 21-25 weeks where it had comparable expression to the control while
expression changed more in female Mllt3ΔHep mice with first a decrease at 10 weeks followed by
an increase at 13 and 21 weeks (Figures 16a,b). When grouped regardless of only age, Mllt1
expression was not significantly changed (17% males vs 13.5% females) when Mllt3 was
knocked out in hepatocytes, but when grouped regardless of both age and sex, expression was
slightly but significantly increased (15.6%) in Mllt3ΔHep mice (Figures 16c,d).
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Figure 16: Mllt1 Increased in Expression in Male and Female Mllt3ΔHep. Mllt1 expression in
(a) male and (b) female Mllt3;Alb-Cre mice grouped by age, (c) just by sex, and (d) regardless of
age and sex. N is the number of mice per group.
Summary of Mllt3ΔCre qRT-PCR Results
Overall, more variability in gene expression occurs in male and female Mllt3ΔHep mice
that decreases as the mice age with little to no differences in expression occurring by 53-57
weeks. When grouped regardless of age, Pck1, Irs2, and Mllt1 did not have changed expression
in male and female Mllt3ΔHep mice. B4galt1, Gck, and Onecut1 expression was also only changed
in the male Mllt3ΔHep mice and there was a statistically significant difference between the male
and female Mllt3ΔHep mice. Gclc was the only gene that was changed in expression in just female
Mllt3ΔHep mice. The remainder of genes were differentially expressed in both male and female
Mllt3 knockout mice. This highlights the differences in gene expression between Mllt3ΔHep mice
and age and/or sex related changes.
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Determine Expression of Differentially Expressed Genes (DEGs) in in Mllt1fl/fl;AlbCre Mice Livers Relative to Mouse Age and Sex
Next, gene expression of the previously mentioned RNA-sequencing differentially
expressed genes of interest was studied in Mllt1fl/fl;Alb-Cre, hereafter called Mllt1ΔCre mice. First
looking at the expression of Mllt1 in male mice at 5 and 12 weeks, there was a significant
decrease in expression in the mice with Mllt1 knocked out in hepatocytes. This was also
observed in female Mllt1ΔCre mice (Figures 17a,b). When grouped regardless of age, both male
and female Mllt1ΔCre mice showed significant knockout of Mllt1 (94% knockdown in males vs
92% in females) with the male mice having more significant of a reduction compared to the
female mice. Grouped regardless of age and sex, the Mllt1 knockout mice had a significant
reduction (93%) in the expression of Mllt1 in the liver compared to the wildtype mice (Figures
17c,d).
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Figure 17: Mllt1 Significantly Reduced in Expression in Male and Female Mllt1ΔHep. Mllt1
expression in (a) male and (b) female Mllt1;Alb-Cre mice grouped by age, (c) just by sex, and (d)
regardless of age and sex. N is the number of mice per group.
Pck1 qRT-PCR Mllt1ΔCre
The expression of Pck1 was changed in the male Mllt1ΔCre mice compared to the age
matched wildtype at only 12 weeks of age. Conversely, at the same ages in female mice, there
was a significant reduction in Pck1 expression in the Mllt1ΔCre mice (Figures 18a,b). When
grouped regardless of age, the female Mllt1ΔCre mice still had a significant reduction in Pck1
expression (19.1% reduction), and the also had more of a change in expression compared to the
male Mllt1 knockout mice (2.6% increase) (Figure 18c). Overall, there was no significant change
in Pck1 expression when grouped regardless of sex and age (9% reduction) (Figure 18d).
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Figure 18: Pck1 Reduced in Expression in Male and Female Mllt1ΔHep. Pck1 expression in (a)
male and (b) female Mllt1;Alb-Cre mice grouped by age, (c) just by sex, and (d) regardless of
age and sex. N is the number of mice per group.
Rorc qRT-PCR Mllt1ΔCre
The expression of Rorc was increased significantly in both age groups in male Mllt1ΔCre
mice while it was only significantly increased at 5 weeks in the female Mllt1 knockouts. At 12
weeks of age, the expression of Rorc was insignificantly changed upon Mllt1 knockout (Figures
19a,b). Grouped regardless of age, there was no change in expression when Mllt1 was knocked
out in the liver of female mice; however, in male Mllt1 knockout mice, the expression of Rorc
was significantly increased (51%). In addition, the expression of Rorc in male Mllt1ΔCre mice was
highly significantly increased compared to the female knockout mice (12% increase in females)
(Figure 19c). Regardless of age and sex, there was a highly statistically significant increase
(31.5%) in Rorc expression in Mllt1ΔCre mice (Figure 19d).
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Figure 19: Rorc Increased in Expression in Male and Female Mllt1ΔHep. Rorc expression in
(a) male and (b) female Mllt1;Alb-Cre mice grouped by age, (c) just by sex, and (d) regardless of
age and sex. N is the number of mice per group.
B4galt1 qRT-PCR Mllt1ΔCre
B4galt1 expression is significantly increased in both male and female Mllt1ΔCre mice at 5
weeks, but at 12 weeks the expression is insignificantly changed in male knockout mice and is
reduced in female knockout mice (Figures 20a,b). When grouped regardless of age, both male
and female Mllt1ΔCre mice had increased B4galt1 expression (61.2% in males, 17.2% in females),
and overall B4galt1 expression was significantly increased (39.2%) in Mllt1 knockout mice
when grouped regardless of both age and sex (Figures 20c,d).
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Figure 20: B4galt1 Expression Increased in Young Male and Female Mllt1ΔHep and Reduced
at Old Ages in Females. B4galt1 expression in (a) male and (b) female Mllt1;Alb-Cre mice
grouped by age, (c) just by sex, and (d) regardless of age and sex. N is the number of mice per
group.
Gclc qRT-PCR Mllt1ΔCre
The expression of Gclc was unchanged in male Mllt1ΔCre mice at both 5 and 12 weeks
while the same ages in female knockout mice had increased expression. Thus, grouping
regardless of age, the female Mllt1ΔCre mice had significantly increased (10.3%) expression in
Gclc while the male knockouts did not (2%). Regardless of both age and sex, there was no
change (6.1%) in the expression of Gclc (Figures 21a-d).
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Figure 21: Gclc Expression was Only Increased in Female Mllt1ΔHep. Gclc expression in (a)
male and (b) female Mllt1;Alb-Cre mice grouped by age, (c) just by sex, and (d) regardless of
age and sex. N is the number of mice per group.
Foxa2 qRT-PCR Mllt1ΔCre
The expression of Foxa2 in male Mllt1ΔCre mice was increased at both 5 and 12 weeks of
age while it was significantly reduced at 12 weeks in female knockout mice (Figures 22a,b).
Thus, when grouped regardless of age, the male Mllt1 knockout mice show a significant overall
increase (55.4%) in Foxa2 expression while the female knockout show a decrease (12%). There
is also a significant difference in Foxa2 expression between the male and female Mllt1ΔCre mice.
When grouped regardless of both age and sex, there was an insignificant change in Foxa2
expression (21.8% increase) since the male and female Mllt1ΔCre mice had opposite changes in
expression (Figures 22c,d).
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Figure 22: Increased Foxa2 Expression in Male Mllt1ΔHep Mice and Decreased in Female
Mllt1ΔHep Mice. Foxa2 expression in (a) male and (b) female Mllt1;Alb-Cre mice grouped by
age, (c) just by sex, and (d) regardless of age and sex. N is the number of mice per group.
Wdtc1 qRT-PCR Mllt1ΔCre
The expression of Wdtc1 was reduced at both 5 and 12 weeks of age in male Mllt1ΔCre
mice, but only significantly so at 5 weeks of age. In female knockout mice, there was not a
significant change of expression at 5 weeks of age while at 12 weeks there was a significant
increase (Figures 23a,b). Only the male Mllt1ΔCre mice had a significant change , a reduction
(17%), in expression when grouped regardless of age, and had a significant difference in
expression compared to the female knockouts (5.5% increase). Grouped regardless of age and
sex there was no change in the expression (6% decrease) of Wdtc1 in Mllt1 knockout mice
compared controls (Figures 23 c,d).
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Figure 23: Wdtc1 Expression was Reduced in Male Mllt1ΔHep Mice and Increased at 12
Weeks in Female Mllt1ΔHep. Wdtc1 expression in (a) male and (b) female Mllt1;Alb-Cre mice
grouped by age, (c) just by sex, and (d) regardless of age and sex. N is the number of mice per
group.
Gck qRT-PCR Mllt1ΔCre
Gck expression was insignificantly increased at 5 weeks and was significantly decreased
at 12 weeks in male Mllt1ΔCre mice (Figure 24a). Similar changes in expression were seen in
female Mllt1 knockout mice, but the increase in expression at 5 weeks was significant (Figure
24b). Since the changes in expression at 5 and 12 weeks were opposite of each other, Gck
expression when grouped regardless of age was not significantly changed in male and female
Mllt1ΔCre mice (26.9% increase in males, 4.3% increase in females). Similarly, when grouped
regardless of age and sex, there was no significant change in Gck expression (15.6% increase)
(Figures 24c,d).
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Figure 24: Male and Female Mllt1ΔHep had Trending or Increased Gck Expression at 5
Weeks and Reduced at 12 Weeks. Gck expression in (a) male and (b) female Mllt1;Alb-Cre
mice grouped by age, (c) just by sex, and (d) regardless of age and sex. N is the number of mice
per group.
Onecut1 qRT-PCR Mllt1ΔCre
Onecut1 expression in male Mllt1ΔCre mice was significantly increased at both 5 and 12
weeks of age (Figure 25a). Conversely, expression was insignificantly changed at 5 weeks in
female Mllt1ΔCre mice and was significantly reduced at 12 weeks (Figure 25b). When grouped
regardless of age, male Mllt1ΔCre mice had significantly increased (253%) expression of Onecut1
while female knockout mice had no significant change (10.5% reduction). Also, male knockout
mice had a significant difference in expression compared to female knockout mice (Figure 25c).
When grouped together regardless of age and sex, there was an overall increase (122%) in
Onecut1 expression when Mllt1 was knocked out in hepatocytes (Figure 25d).
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Figure 25: Onecut1 Expression was Increased in Male Mllt1ΔHep Mice but Reduced at 12
Weeks in Female Mllt1ΔHep Mice. Onecut1 expression in (a) male and (b) female Mllt1;Alb-Cre
mice grouped by age, (c) just by sex, and (d) regardless of age and sex. N is the number of mice
per group.
Per2 qRT-PCR Mllt1ΔCre
Per2 expression was reduced at both 5 and 12 weeks in male Mllt1ΔCre mice but was only
significantly reduced at 5 weeks and had a large range at 12 weeks (Figure 26a). Similar results
were seen in female Mllt1ΔCre mice with a significant reduction in the expression of Per2 at 5
weeks and an insignificant change occurring at 12 weeks (Figure 26b). Regardless of age, both
male and female Mllt1ΔCre mice showed reduced (33.4% reduction in males, 24.3% reduction in
females) Per2 expression, but only the male knockout mice were significantly different (Figure
26c). Grouped regardless of age and sex, there was a reduction( (28.9%) in Per2 expression in
Mllt1ΔCre mice (Figure 26d).
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Figure 26: Per2 Expression was Reduced at 5 Weeks in Male and Female Mllt1ΔHep Mice.
Per2 expression in (a) male and (b) female Mllt1;Alb-Cre mice grouped by age, (c) just by sex,
and (d) regardless of age and sex. N is the number of mice per group.
Irs2 qRT-PCR Mllt1ΔCre
The expression of Irs2 in male liver specific Mllt1ΔCre mice was significantly increased at
5 weeks of age and remained insignificantly increased at 12 weeks (Figure 27a). The female
Mllt1ΔCre mice also had a significant increase in Irs2 expression at 5 weeks, but at 12 weeks there
was a significant reduction in this expression (Figure 27b). Grouped regardless of age, only the
male Mllt1ΔCre mice showed a significant increase (27.7%) in Irs2 expression. The female
knockout mice also had increased (13.6%) expression but was insignificant (Figure 27c). When
Irs2 expression was looked at grouped regardless of the age and sex of mice, there was an overall
increase (20.7%) in expression in the knockout mice (Figure 27d).
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Figure 27: Increased Irs2 Expression in Male and Female Mllt1ΔHep Mice at 5 Weeks and
Reduced at 12 Weeks in Female Knockouts. Irs2 expression in (a) male and (b) female
Mllt1;Alb-Cre mice grouped by age, (c) just by sex, and (d) regardless of age and sex. N is the
number of mice per group.
Mllt3 qRT-PCR Mllt1ΔCre
The final gene of interest, Mllt3, was insignificantly changed in expression in male
Mllt1ΔCre mice, but had increased expression at 5 weeks followed by reduced expression at 12
weeks in the female knockout mice (Figures 28a,b). Grouped regardless of only age and
regardless of both age and sex, there was no change in Mllt3 expression in both male (7%
reduction) and female (2.8% increase) Mllt1 knockout mice (1.7% reduction regardless of age
and sex) (Figures 28c,d).
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Figure 28: Changing Mllt3 Expression in Female Mllt1ΔHep Mice. Mllt3 expression in (a) male
and (b) female Mllt1;Alb-Cre mice grouped by age, (c) just by sex, and (d) regardless of age and
sex. N is the number of mice per group.
Summary of Mllt1ΔCre qRT-PCR Results
qRT-PCR was only done on 5- and 12-week-old Mllt3ΔHep and control mice and
variability were observed at these younger age points. Since only young mice were available,
less age-related sex expression differences were observed. Male Mllt1ΔHep mice had different
Rorc, Wdtc1, Onecut1, Per2, and Irs2 expression compared to female Mllt3ΔHep mice. Female
Mllt3ΔHep mice had different expressions in Pck1 and Gclc compared to the male knockout mice.
The remaining genes had different expressions in both male and female Mllt3ΔHep mice. Overall,
there were still differences in expression of the genes of interest when Mllt1 was knocked out.
Gene Expression Comparisons Between Mllt3;Alb-Cre and Mllt1;Alb-Cre Mice
Gene expression in Mllt3ΔHep and Mllt1ΔHep mice were compared at 5 weeks of age. Pck1
expression was not significantly different between male Mllt3 and Mllt1 knockout mice while
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there was a small but statistical difference between genotypes in female mice with lower
expression in Mllt1 mice (Figure 29a,b). Comparisons were also done between 12-week-old
Mllt3ΔHep and Mllt1ΔHep mice. Pck1 expression was statistically different between the two
genotypes with higher expression in Mllt3 knockout mice while the Mllt1 had reduced
expression. Similar differences in expression were seen in female mice but was more statistically
significant (Figures 29c,d).

Figure 29: Pck1 Expression Difference at 12 Weeks Between Mllt3ΔHep and Mllt1ΔHep Male
and Female Mice Pck1 expression in male and female Mllt3;Alb-Cre mice and Mllt1;Alb-Cre
mice compared at 5 (a, b) and 12 (c, d) weeks of age.
Similarly, B4galt1 expression at 5 weeks was not different in male knockout mice while there
was small statistical difference between the genotypes in female knockout mice with the higher
expression in Mllt1 (Figures 30a,b). B4galt1 expression in 12-week-old male mice was higher in
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Mllt3fl/fl;Alb-Cre mice, and there was a highly statistically significant difference between the
genotypes. And again, there was no difference in B4galt1 expression in female mice (Figures
30c,d).

Figure 30: B4galt1 Expression Differs Between Female Mllt3ΔHep and Mllt1ΔHep Mice at 5
Weeks and Male Mice at 12 Weeks. B4galt1 expression in male and female Mllt3;Alb-Cre
mice and Mllt1;Alb-Cre mice compared at 5 (a, b) and 12 (c, d) weeks of age.
Foxa2 expression at 5 weeks again did not differ in male knockout mice and again did in
female knockout mice and higher expression was seen in Mllt3 liver specific knockout mice
(Figures 31a,b). Foxa2 expression at 12 weeks did differ between Mllt3 and Mllt1ΔHep mice with
higher expression in Mllt3 knockout mice in both male and female comparisons (Figures 31c,d).
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Figure 31: Foxa2 Expression Different Between Mllt3ΔHep and Mllt1ΔHep Mice at 12 Weeks,
and Males at 5 Weeks. Foxa2 expression in male and female Mllt3;Alb-Cre mice and
Mllt1;Alb-Cre mice compared at 5 (a, b)and 12 (c, d)weeks of age.
Gck expression did statistically differ in 5 week male knockout mice and Mllt3ΔHep had higher
expression. Expression of Glucokinase did not differ between female knockout mice (Figures
32a,b). Glucokinase expression was statistically significantly different between male Mllt3ΔHep
and Mllt1ΔHep mice with Mllt3 again having higher expression at 12 weeks. In female knockout
mice however, there was still no significant difference in Gck expression between the genotypes
(Figures 32c,d).
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Figure 32: Gck Expression was Significantly Different Only Between Mllt3ΔHep and
Mllt1ΔHep Male Mice Gck expression in male and female Mllt3;Alb-Cre mice and Mllt1;Alb-Cre
mice compared at 5 (a, b) and 12 (c, d) weeks of age.
Per2 and Irs2 expression were statistically different between genotypes at 5 weeks in male
mice. Mltl3 liver-specific knockouts had higher Per2 expression while Mllt1 had slightly higher
Irs2 (Figures 33a & 34a). Per2 expression was higher in the female Mllt3ΔHep while Irs2 did not
differ between genotypes (Figures 33b & 34b). Per2 expression was highly statistically different
in 12-week-old male liver specific knockout mice with higher expression in Mllt3ΔHep mice.
Again, there was no difference in Per2 expression between Mllt3ΔHep and Mllt1ΔHep knockout
female mice at 12 weeks (Figures 33c,d). Finally, the expression of Irs2 showed similar
differences in expression in male and female knockout mice. There was a highly statistically
significant difference in Irs2 expression in male liver specific knockout mice with higher
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expression in Mllt3ΔHep. There was again no significant difference in Irs2 expression between
Mllt3 and Mllt1 liver specific knockouts in female mice (Figures 34c,d).

Figure 33: Per2 Expression was Increased in Mllt3ΔHep Compared to Mllt1ΔHep Mice Per2
expression in male and female Mllt3;Alb-Cre mice and Mllt1;Alb-Cre mice compared at 5 (a, b)
and 12 (a, b) weeks of age.
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Figure 34: Irs2 Expression Only Differed Between Male Mllt3ΔHep and Mllt1ΔHep Mice Irs2
expression in male and female Mllt3;Alb-Cre mice and Mllt1;Alb-Cre mice compared at 5 (a, b)
and 12 (a, b) weeks of age.
Rorc, Gclc, Wdtc1, and Onecut1 did not have differences in expression between genotypes at
5 weeks in both male and female Mllt3fl/fl;Alb-Cre and Mllt1fl/fl;Alb-Cre mice (Figures
35/36/37/38 a,b). The expression of Rorc in male mice at 12 weeks old was highly statistically
different between the liver specific Mllt3 and Mllt1 knockouts. Again, the Mllt3fl/fl;Alb-Cre mice
had higher expression of Rorc than the Mllt1fl/fl;Alb-Cre mice. Female knockout mice had no
significant difference between the genotypes (Figures 35c,d). Similar to expression of Rorc, Gclc
expression did not differ in comparisons between genotypes in male mice at 12 weeks while in
female mice there was a slight difference in Gclc expression (Figures 36c,d). Wdtc1 relative

65

expression was not statistically different between the two genotypes at 12 weeks of age in both
male and female knockout mice (Figures 37c,d). While there was a difference in Onecut1
expression in 12-week-old male knockout mice compared between genotypes, it was not
statistically significant because of the high standard deviations in the Mllt3fl/fl;Alb-Cre mice.
There was also no difference in Onecut1 expression between genotypes in female mice (Figures
38c,d).

Figure 35: Rorc Expression Only Statistically Different in Male Mice at 12 Weeks. Rorc
expression in male and female Mllt3;Alb-Cre mice and Mllt1;Alb-Cre mice compared at 5 (a, b)
and 12 (a, b) weeks of age.
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Figure 36: Gclc Expression Only Differs Between Mllt3ΔHep and Mllt1ΔHep Female Mice at 12
Weeks. Gclc expression in male and female Mllt3;Alb-Cre mice and Mllt1;Alb-Cre mice
compared at 5 (a, b) and 12 (a, b) weeks of age.
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Figure 37:Wdtc1 Expression Was Unchanged Between Mllt3ΔHep and Mllt1ΔHep Mice Wdtc1
expression in male and female Mllt3;Alb-Cre mice and Mllt1;Alb-Cre mice compared at 5 (a, b)
and 12 (a, b) weeks of age.
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Figure 38: Onecut1 Expression was Unchanged Between Mllt3ΔHep and Mllt1ΔHep Mice
Onecut1 expression in male and female Mllt3;Alb-Cre mice and Mllt1;Alb-Cre mice compared at
5 (a, b) and 12 (a, b) weeks of age.
Gene Expression in Mllt3fl/fl;Rosa26-CreERT2 and Mllt1fl/fl;Rosa26-CreERT2 Mice
Livers in Different Age Groups and Sexes
To determine whether there was a good knockout of Mllt3 in the whole-body
Mllt3fl/fl;Rosa26-CreERT2 mice, qRT-PCR for Mllt3 expression was performed on RNA isolated
from the liver. Results show that there was a highly significant knockout of Mllt3 within the liver
of these whole-body knockout male (92.1 reduction) and female (93.3% reduction) mice. This
knockout was still observed when the data was grouped regardless of only sex (92.7% reduction)
because the mice from both sexes were all between 64 to 67 weeks old and were 58- or 59-weeks
post-Tamoxifen injection (Figures 39a,b).
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Figure 39: Mllt3 Expression was Significantly Knocked Down in Male and Female
Mllt3;Rosa26Cre. Mllt3 expression in (a)male and female Mllt1;Rosa26Cre mice grouped by
sex, and (b)regardless of sex. N is the number of mice per group.
Pck1 qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
Pck1 expression was statistically significantly decreased (28.1% reduction) in male Mllt3
Rosa26cre knockout mice but was insignificantly changed in female knockout mice (10.3%
increase). Due to opposing expression changes in male and female knockout mice, Pck1
expression was not significantly changed (9% decrease) in the Mllt3 whole-body knockout mice
when grouped regardless of sex (Figures 40a,b).

Figure 40: Pck1 Expression was Reduced in Male Mllt3;Rosa26Cre. Pck1 expression in
(a)male and female Mllt1;Rosa26Cre mice grouped by sex, and (b)regardless of sex. N is the
number of mice per group.
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Rorc qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
The expression of Rorc was increased (24.2%) in expression in male Mllt3 whole-body
knockout mice while expression was insignificantly changed (5.1% increase) in female knockout
mice compared to controls. In addition, there was a statistically significant difference in the
expression of Rorc between male and female Mllt3 knockout mice. When grouped regardless of
sex related differences, Mllt3;Rosa26-CreERT2 mice knockout mice had higher (14.7% increase)
Rorc expression compared to grouped controls (Figures 41a,b).

Figure 41: Rorc Expression was Increased in Male Mllt3;Rosa26Cre Mice and Regardless
of Sex. Rorc expression in (a)male and female Mllt1;Rosa26Cre mice grouped by sex, and
(b)regardless of sex. N is the number of mice per group.
B4galt1 qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
B4galt1 expression grouped by sex showed similar results where male Mllt3 knockout
mice had increased (13.5%) expression of B4galt1 while the expression in female knockout mice
was unchanged (2% decrease). However, when grouped with all Mllt3 whole-body knockouts
compared to grouped controls, there was not a significant change (5.8 increase) in B4galt1
expression (Figures 42a,b).
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Figure 42: B4galt1 Expression Increased in Male Mllt3;Rosa26Cre Mice. B4galt1 expression
in (a)male and female Mllt1;Rosa26Cre mice grouped by sex, and (b)regardless of sex. N is the
number of mice per group.
Gclc qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
The expression of Gclc grouped by sex was again similar to Rorc and B4galt1 where the
male Mllt3 knockout mice had increased (21.1%) expression of Gclc while the female wholebody knockouts did not (5.1%). Grouped regardless of sex differences, the expression of Gclc
was not significantly changed (13.1% increase) when Mllt3 was deleted in Rosa26-CreERT2 mice
by Tamoxifen injection (Figures 43a,b).

Figure 43: Gclc Expression Increased in Male Mllt3;Rosa26Cre Mice. Gclc expression in
(a)male and female Mllt1;Rosa26Cre mice grouped by sex, and (b)regardless of sex. N is the
number of mice per group.
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Foxa2 qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
The expression of Foxa2 was trending towards increased in expression in both male
(37.8%) and female (5.9%) Mllt3 whole-body knockout mice, but the change in expression was
not statistically significant. This insignificant increase (21.8%) was also observed when mice
were grouped without sex as a factor (Figures 44a,b).

Figure 44: Foxa2 Expression not Significantly Changed in Mllt3;Rosa26Cre Mice. Foxa2
expression in (a)male and female Mllt1;Rosa26Cre mice grouped by sex, and (b)regardless of
sex. N is the number of mice per group.
Wdtc1 qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
Wdtc1 expression was insignificantly increased (8.5%) in male Mllt3;Rosa26-CreERT2
mice while it was slightly yet statistically significantly increase (6.4%) in female knockout mice.
Since both sexes had an increase in Wdct1 expression, when grouped regardless of sex there was
a statistically significant increase (7.5%) in expression of Wdtc1 in Mllt3 whole-body knockout
mice (Figures 45a,b).
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Figure 45: Wdtc1 Expression was Slightly Increased in Female Mllt3;Rosa26Cre Mice.
Wdtc1 expression in (a)male and female Mllt1;Rosa26Cre mice grouped by sex, and
(b)regardless of sex. N is the number of mice per group.
Gck qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
Male and female Mllt3;Rosa26-CreERT2 mice did not have significant changes (14.4%
increase in males, 2.2% decrease in females) in the expression of Gck and grouped regardless of
sex there was also no difference (6.1% increase) in Gck expression when Mllt3 was deleted in
the whole-body knockout (Figures 46a,b).

Figure 46: Gck Expression was Unchanged in Male and Female Mllt3;Rosa26Cre Mice. Gck
expression in (a)male and female Mllt1;Rosa26Cre mice grouped by sex, and (b)regardless of
sex. N is the number of mice per group.
Onecut1 qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
Onecut1 expression was statistically significantly increased (131%) in male Mllt3 wholebody knockout mice while it was not changed (5.8% increase) in the females. Also, there was a
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difference in expression between the male and female Mllt3 knockouts. Overall, there was a
statistical increase (68.4%) in Onecut1 expression in Mllt3;Rosa26-CreERT2 mice compared to
controls (Figures 47a,b).

Figure 47: Onecut1 Expression was Significantly Increased in Male Mllt3;Rosa26Cre Mice
and Regardless of Sex. Onecut1 expression in (a)male and female Mllt1;Rosa26Cre mice
grouped by sex, and (b)regardless of sex. N is the number of mice per group.
Per2 qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
Per2 expression was trending toward increased in both male (52.8% increase) and female
(13.3% increase) Mllt3 whole-body knockout mice, but it was not statistically significant.
Grouped regardless of sex, there was again a trend towards an increase (33.1%) in Per2
expression in the knockout mice that was not statistically significant (Figures 48a,b).

Figure 48: Per2 Expression was Unchanged in Male and Female Mllt3;Rosa26Cre Mice.
Per2 expression in (a)male and female Mllt1;Rosa26Cre mice grouped by sex, and (b)regardless
of sex. N is the number of mice per group.
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Irs2 qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
Irs2 expression was trending toward decreased (19.9%) expression but not statistically
so in male Mllt3 knockout mice while it was significantly increase (34%)in the female Mllt3
knockout mice. There was also a statistically significant difference in the relative expression of
Irs2 between male and female Mllt3 knockout mice. Since male and female knockout mice had
opposite Irs2 expression, when grouped ignoring sex differences, there was not a significant
change (7.1% increase) in the expression of Irs2 in the knockout mice (Figures 49a,b).

Figure 49: Irs2 Expression in Female Mllt3;Rosa26Cre Mice. Irs2 expression in (a)male and
female Mllt1;Rosa26Cre mice grouped by sex, and (b)regardless of sex. N is the number of mice
per group.
Mllt1 qRT-PCR Mllt3fl/fl;Rosa26-CreERT2
Finally, Mllt1 relative expression was unchanged (6% decrease) in male Mllt3 knockout
mice while it was highly statistically significantly increased (16%) in female knockout mice. In
addition, there was a statistical difference in Mllt1 expression between the male and female Mllt3
knockouts. There was no overall difference (5% increase) in Mllt1 expression when grouped
regardless of sex (Figures 50a,b).
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Figure 50: Mllt1 Expression was Increased in Female Mllt3;Rosa26Cre Mice. Mllt1
expression in (a)male and female Mllt1;Rosa26Cre mice grouped by sex, and (b)regardless of
sex. N is the number of mice per group.
Summary of Mllt3fl/fl;Rosa26-CreERT2 qRT-PCR Results
Male and female Mllt3fl/fl;Rosa26-Cre mice gene expressions were only observed at one
age group, so only sex-related differences in expression were studied. Pck1, Rorc, B4galt1, Gclc,
Onecut1 were all statistically different in expression in male Mllt3fl/fl;Rosa26-Cre mice but not
female while Mllt1, Irs2, and Wdtc1 were changed in female Mllt3fl/fl;Rosa26-Cre mice. The
remaining genes had no difference in expression in either sex. Interestingly, more sex differences
occurred when Mllt3 was knocked out in the whole body and not just the liver.
Mllt1fl/fl;Rosa26-CreERT2 Mice
In Mllt1;Rosa26-CreERT2 mice there was a very good efficient of Mllt1 in both male
(97.1% reduction) and female (97.4% reduction) knockout mice compared to controls and when
grouped regardless of sex differences there was also a significant knockout (97.3%) (Figures
51a,b).
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Figure 51: Mllt1 Expression is Knocked Down in Male and Female Mllt1;Rosa26Cre. Mllt1
expression in (a)male and female Mllt1;Rosa26Cre mice grouped by sex, and (b)regardless of
sex. N is the number of mice per group.
Pck1 & Rorc qRT-PCR Mllt1fl/fl;Rosa26-CreERT2
In both male and female Mllt1 knockout mice there was an increase (74.7% males, 107%
females) in the relative expression of Pck1. Since both sexes had increased Pck1 expression,
there was an increase (90.9%) in expression still seen when grouped just by genotype (Figures
52a,b). Rorc expression was trending toward increased (23.1%) expression in male Mllt1
knockout mice and was slightly yet statistically significantly decreased (20.4%) in female Mllt1
knockout mice. There was also a statistical difference in expression between the male and female
Mllt1 knockout mice, and because of this difference there was no significant change (1.35%
increase) in Rorc expression grouped regardless of sex (Figures 52c,d).
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Figure 52: Pck1 Expression was Increased in Male and Female Mllt1;Rosa26Cre While
Rorc Expression was Reduced in Female Mllt1;Rosa26Cre. Pck1 & Rorc expression in
(a,c)male and female Mllt1;Rosa26Cre mice grouped by sex, and (b,d)regardless of sex. N is the
number of mice per group.
B4galt1 & Gclc qRT-PCR Mllt1fl/fl;Rosa26-CreERT2
The expression of B4galt1 was insignificantly changed in male (12.6% increase) and
female (14% decrease) Mllt1 knockout mice and when grouped together (1% decrease) (Figures
53a,b). Gclc also had an insignificant change in relative expression similar to B4galt1 (11.1%
increase in males, 0.9% increase in females, 13.9% increase regardless of sex) (Figures 53c,d).
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Figure 53: B4galt1 & Gclc Expression was Unchanged in Male and Female
Mllt1;Rosa26Cre Mice. B4galt1 & Gclc expression in (a,c)male and female Mllt1;Rosa26Cre
mice grouped by sex, and (b,d)regardless of sex. N is the number of mice per group.
Foxa2 & Wdtc1 qRT-PCR Mllt1fl/fl;Rosa26-CreERT2
Foxa2 relative expression was significantly increased (220%) in male Mllt1;Rosa26CreERT2 mice and was not changed (24% decrease) in female knockout mice. In addition, there
was a statistical difference in Foxa2 expression between male and female knockout mice. There
was a trend towards increased (98%) Foxa2 expression in the Mllt1 knockout mice grouped by
genotype, but it was not statistically significant (Figures 54a,b). The expression of Wdtc1 was
insignificantly increased in both male (18.2%) and female (14.2%) Mllt1;Rosa26-CreERT2 mice
which was also observed when grouped regardless of sex (16.2% increase) (Figures 54c,d).
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Figure 54: Foxa2 Expression was Increased in Male Mllt1;Rosa26Cre Mice while Wdtc1
Expression was Unchanged. Foxa2 & Wdtc1 expression in (a,c)male and female
Mllt1;Rosa26Cre mice grouped by sex, and (b,d)regardless of sex. N is the number of mice per
group.
Gck & Onecut1 qRT-PCR Mllt1fl/fl;Rosa26-CreERT2
Gck expression was statistically significantly decreased (24.4%) in female Mllt1 knockout
mice while the male knockouts trended toward increased (155%) expression that was not
statistically significant because of variability. Overall, there was no significant change (65.2%)
in Gck expression due to the opposing expressions in male and female knockout mice (Figures
55a,b). The expression of Onecut1 followed similar patterns as the expression of Gck in the
whole body Mllt1 knockout male and female mice. The only differences were that male
knockouts had a statistically significant increase in Onceut1 expression, and the female
knockouts were not decreased (Figures 55c,d)
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Figure 55: Gck Expression was Reduced in Female Mllt1;Rosa26Cre Mice while Onecut1
was Increased in Male Mice. Gck & Onecut1 expression in (a,c)male and female
Mllt1;Rosa26Cre mice grouped by sex, and (b,d)regardless of sex. N is the number of mice per
group.
Per2, Irs2, & Mllt3 qRT-PCR Mllt1fl/fl;Rosa26-CreERT2
Per2 expression was trending towards an increase (31.3%) in male Mllt1 knockout mice and
towards a decrease (24%) in female knockout mice. There was also no change (3.8% increase) in
relative Per2 expression when grouped ignoring sex (Figures 56a,b).Irs2 expression was
increased in Mllt1 male (75.1%) and female (37%) knockout mice but was only statistically
significantly so in the male mice. Since both sexes had increased Irs2 expression, when grouped
regardless of sex there was a statistically significant increase (56%) in Irs2 in the Mllt1;Rosa26CreERT2 mice (Figures 56c,d). Finally, Mllt3 expression was statistically decreased (17.6%
reduction) in male Mllt1 knockout mice and was not significantly (18.8% increase) changed in
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female knockout mice. There was also a statistical difference in Mllt3 expression between male
and female Mllt1;Rosa26-CreERT2 mice. Overall, there was no change (0.6% increase) in Mllt3
expression when grouped regardless of sex related differences (Figures 56e,f).

Figure 56: Per2 Expression was Unchanged, Irs2 was Increased in Male, and Mllt3
Expression was Reduced in Male Mllt1;Rosa26Cre Mice. Per2, Irs2 & Mllt3 expression in
(a,c,e)male and female Mllt1;Rosa26Cre mice grouped by sex, and (b,d,f)regardless of sex. N is
the number of mice per group.
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Summary of Mllt1fl/fl;Rosa26-CreERT2 qRT-PCR Results
Similar to Mllt3;Rosa26-Cre mice, Mllt1;Rosa26-Cre mice were also studied at one age
group so only differences related to sex were studied. Foxa2, Onecut1, Irs2, and Mllt3 were all
statistically different in only male Mllt1;Rosa26-Cre mice while Gck and Rorc were different in
female mice. Only Pck1 was changed in expression in both male and female Mllt1;Rosa26-Cre
mice and the remainder of genes were not significantly altered. More individual sex differences
occurred in Mllt1;Rosa26-Cre mice than in Mllt3;Alb-Cre.
Gene Expression Comparisons Between Rosa26-Cre and Mllt3;Alb-Cre Mice
Gene expression comparisons were made between 50-week-old Mllt3fl/fl;Alb-Cre mice and
the, Mllt3;Rosa26-CreERT2 and Mllt1;Rosa26-CreERT2 mice because it was relatively comparable
to the time post-Tamoxifen injection in the Rosa26-Cre mice (58 weeks). Pck1 expression was
statistically different between Mllt3fl/fl;Alb-Cre and Mllt1;Rosa26-CreERT2 male mice and
between the Mllt3 and Mllt1 Rosa26-Cre mice. The Mllt1 whole-body knockout mice had higher
expression of Pck1 in both circumstances. Similar comparisons in Pck1 expression were
observed in female mice (Figures 57a,b). Rorc expression was statistically different when
compared between Mllt3fl/fl;Alb-Cre mice and both sets of Rosa26-Cre mice. In female mice,
there was a difference in expression when Mllt1;Rosa26-CreERT2 mice were compared to Mllt3
liver-specific and Mllt3 whole-body knockout mice. The Mllt1 whole-body knockout mice had
decreased expression compared to the Mllt3 genotypes (Figures 57c,d). The expression of
B4galt1 was only statistically different between the Mllt3fl/fl;Alb-Cre and Mllt3;Rosa26-CreERT2
male knockouts while expression was only changed in the female knockouts between
Mllt3fl/fl;Alb-Cre, Mllt1;Rosa26-CreERT2 mice (Figures 57e,f). There was no difference in Gclc
expression between genotypes in male knockout mice, but in female knockout mice there was a
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difference when Gclc expression was compared between Mllt3fl/fl;Alb-Cre knockouts and either
Mllt3;Rosa26-CreERT2 or Mllt1;Rosa26-CreERT2 mice (Figures 58a,b). Foxa2 expression in male
knockout mice was showed a statistical difference when Mllt3fl/fl;Alb-Cre mice were compared to
Mllt3;Rosa26-CreERT2 or Mllt1;Rosa26-CreERT2 mice. The whole-body knockout mice had higher
expression than the liver-specific male knockouts with Mllt1 having the higher expression of the
two genotypes. In comparison, female knockout mice only showed a difference in Foxa2
expression between Mllt3;Rosa26-CreERT2 and Mllt1;Rosa26-CreERT2 mice where Mllt1 female
knockouts had lower expression (Figures 58c,d). The expression of Wdtc1 did not differ between
genotypes when looking at both male and female knockout mice (Figures 57e,f).
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Figure 57: Pck1, Rorc & B4galt1 Expression Comparison Between in Male and Female
Mllt3;Alb-Cre , Mllt3,Rosa26Cre and Mllt1;Rosa26Cre. Pck1, Rorc & B4galt1 expression in
(a,c,e)male mice and (b,d,f) female mice compared between genotypes. N is the number of mice
per group.
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Figure 58: Gclc, Foxa2 & Wdtc1 Expression Comparison Between in Male and Female
Mllt3;Alb-Cre , Mllt3,Rosa26Cre and Mllt1;Rosa26Cre. Gclc, Foxa2 & Wdtc1 expression in
(a,c,e)male mice and (b,d,f) female mice compared between genotypes. N is the number of mice
per group.
Glucokinase relative expression in male knockout mice only differed in expression between
Mllt3fl/fl;Alb-Cre and Mllt1;Rosa26-CreERT2 mice where Mllt1 had higher Gck expression
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compared to the liver-specific Mllt3 knockout. Similarly, Gck expression in female knockout
mice was only statistically different between Mllt3fl/fl;Alb-Cre and Mllt1;Rosa26-CreERT2 mice,
but in this comparison Mllt1 had lower Gck expression (Figures 59a,b). Differences in
expression of Onecut1 were seen in male knockout mice when compared between Mllt3fl/fl;AlbCre and Mllt3;Rosa26-CreERT2 mice and also Mllt3fl/fl;Alb-Cre and Mllt1;Rosa26-CreERT2 mice.
Both whole-body knockout genotypes had higher Onecut1 expression than the liver-specific
Mllt3 knockout with Mllt1;Rosa26-Cre having the higher expression of the two (Figures 59c,d).
The expression of Per2 was insignificantly different between genotypes in male mice while there
was a statistical difference in expression between Mllt3fl/fl;Alb-Cre and Mllt1;Rosa26-CreERT2 in
female mice. Mllt3fl/fl;Alb-Cre knockout female mice had higher Per2 expression than
Mllt1;Rosa26-CreERT2 mice (Figures 59e,f). Finally, Irs2 expression in male mice was
statistically different between Mllt3fl/fl;Alb-Cre and Mllt1;Rosa26-CreERT2 mice, and between the
two whole-body knockout genotypes. Mllt1;Rosa26-CreERT2 male knockout mice had increased
expression while the other two genotypes had slightly decreased expression. In comparison, the
expression of Irs2 in female mice did not differ between genotypes (Figures 59g,h).
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Figure 59: Gck, Onecut1, Per2 & Irs2 Expression Comparison Between in Male and
Female Mllt3;Alb-Cre , Mllt3,Rosa26Cre and Mllt1;Rosa26Cre. Gck, Onecut1, Per2 & Irs2
expression in (a,c,e,g)male mice and (b,d,f,h) female mice compared between genotypes. N is the
number of mice per group.
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Examine the Role of a Hepatic Mllt3 Knockout on Liver Mitochondrial Function
Enrichment of Liver Mitochondria and Protein Quantification
After dounce homogenization and differential centrifugation to enrich for liver mitochondria,
estern blot was used to determine enrichment of mitochondria proteins at different steps of the
process. An antibody mixture that contained antibodies specific for ATP5a (mitochondria),
GAPDH (cystolic membrane), and Histone H3 (nuclear membrane) was used to develop the blot.
Lane 1 contained the whole cell lysate and distinct bands for GAPDH and Histone H3 were
present while the band for ATP5A was fainter. The cytosolic fraction (Lane 2 800xg
supernatant) showed enrichment for the cytosolic protein GAPDH and an even fainter band for
ATP5a. The nuclear fraction (lane 3; 800xg pellet) was enriched for Histone H3, contained
significant ATP5a, and had less GAPDH. The 8,000xg supernatant (lane 4) shows depletion of
Histone H3, decreased GAPDH, and enrichment of ATP5a. The final step of enrichment which
should contain intact mitochondria was the 8,000xg pellet (lane 5) which showed enrichment of
ATP5a and depletion of GAPDH and Histone H3 (Figure 60). The enriched mitochondrial
fraction was used for mitochondrial function assays.

Figure 60:Western Blot Testing for Enrichment of Mitochondria. Enrichment of
mitochondria at each step of the enrichment protocol was tested by western blot to observe
mitochondrial enrichment in the final product (lane 5).
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Quantification of enriched mitochondria in the fractions was tested by western blot. It
was found that not all the samples had the same amount of enrichment, and different volumes of
enriched mitochondria were used for western blot. Most pairs studied by the mitochondrial
function assays had similar enrichment by western blot and could still be directly compared to
one another. Of the pairs that differed, mathematical analysis was done to normalize the samples
to one another so comparisons could still be made (Figure 61).

Figure 61:Western Blot for Enrichment of Mitochondria in Seahorse Samples. Enrichment
of mitochondria used for Seahorse Assays to test for differences in mitochondrial enrichment.
Brackets indicate mouse pairs compared in Seahorse Assays.
Determine the Contribution of Mllt3 to Mitochondrial Function Relative to Mouse Age and
Sex
Seahorse Assays were performed to observe the function of mitochondria when Mllt3
was knocked out in hepatocytes compared to control wildtype mice. 16.67μg of enriched
mitochondria was loaded per well in pentuplicate reactions immediately after enrichment and
quantification of mitochondria, so there was no way to test for enriched protein fractions until
after the Seahorse Assay was done. The mitochondria enriched from liver tissue of one year old
male Mllt3fl/fl;Alb-Cre mice compared to age and sex matched control male mice had no
significant difference of the oxygen consumption rate (OCR, pmol/min) during basal respiration
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in the starting minutes of the Seahorse Assay. Upon addition of ADP (the limiting factor of
oxygen consumption in the Electron Transport Chain), both the Mllt3 liver specific knockout
mouse and the control had increased oxygen consumption rate with the knockout being higher
than the control. When Oligomycin (inhibits complex 5/ATP Synthease of the Electron
Transport Chain thus inhibiting electron flow and ATP production) was injected into the wells of
the plate, both the Mllt3 knockout and control had reduced oxygen consumption rate and the
knockout remained slightly higher. Carbonyl cyanide-4 (trifluromethoxy) phenylhydrazone
(FCCP) (uncouples the proton gradient of the Electron Transport Chain which disturbs the
mitochondrial membrane potential) injection resulted in increased oxygen consumption rate in
both the liver specific Mllt3 knockout and the wildtype control. Again the knockout upheld a
higher oxygen consumption rate. The final addition of the combination of Rotenone (complex 1
inhibitor) and Antimycin A (complex 3 inhibitor; both work together to inhibit mitochondrial
respiration) resulted in reduction of the oxygen consumption rate of Mllt3 liver-specific knockout
and control mice, and the difference between the samples was negligible. Finally, the last
measurement of non-mitochondrial oxygen consumption had very similar oxygen consumption
rate between the Mllt3 knockout and wildtype (Figure 62b).
The second set of 1 year old male mice contained two Mllt3fl/fl;Alb-Cre mice and two
control mice that were cage and littermates. When the first wildtype was compared to the Mllt3
knockout, there was slight but insignificant increase in oxygen consumption rate in the Mllt3
knockout mice irrespective of what drug was injected. With adjustment on enrichment of
mitochondria based on the western blot, the Mllt3 knockout still had higher oxygen consumption
rate at all points (Figures 62c). Lastly, when the second wildtype was compared to the other
paired Mllt3 knockout, there was a slight increase in oxygen consumption rate upon injection of
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ADP. This increase was insignificant after the subsequent injections of Oligomycin, FCCP, and
the combination of Rotenone and Antimycin A (Figure 62d).

Figure 62: Seahorse Assay Testing Mitochondrial Function in Male Mllt3;Alb-Cre Mice
56/57 Weeks of Age Showed Variable Function. Mitochondria functional assay testing
changes in mitochondrial function in Mllt3ΔHep male mice 56/57 weeks old. (a) Modified from
Agilent.
The initial set of 1 year old female mice were again cage and littermates. When the first
wildtype mouse was compared to the Mllt1ΔCre mouse, there was no difference in oxygen
consumption rate throughout the Seahorse Assay (Figure 63a). The other comparison of this set
of mice between wildtype mouse and the Mllt1ΔCre mouse showed an increased oxygen
consumption rate in the knockout mouse, but it was overall an insignificant difference. When
adjusted based on enrichment, the wildtype mouse had higher oxygen consumption rate at all
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points (Figure 63b). The last Seahorse Assay performed on one year old female mice had both
samples started with a similar oxygen consumption rate for basal respiration, but the knockout
mouse had an increased oxygen consumption rate upon injection of ADP, and again maintained
this until the end of the Seahorse Assay (Figure 63c). A Seahorse Assay was also done on a pair
of young (6 weeks) female mice and there was no significant difference in oxygen consumption
rate across all time points and after drug injections (Figure 63d).

Figure 63: Seahorse Assay Testing Mitochondrial Function in Male Mllt3;Alb-Cre Mice
56/57 Weeks of Age. Mitochondria functional assay testing changes in mitochondrial function in
Mllt3ΔHep male mice 56/57 weeks old.
Overall, there appears to be large differences in mitochondrial function seen in the
Seahorse Assays depending on how samples are compared. From the western blot to test
mitochondrial enrichment, not all the samples had equal enrichment occurring which could
explain some of the differences within the Seahorse Assays. Of the pairs that had different
enrichment that was adjusted for, there were more noticeable differences occurring in the results.
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Unfortunately, enrichment can’t be studied by western blot before the functional assays because
these assays required fresh liver and enriched mitochondria which is why equal enrichment was
not achieved in the Seahorse Assays.
Impact of Mllt3 on Liver Mitochondrial Quantity
Quantitative PCR was performed on mitochondrial DNA isolated from the liver of
Mllt3fl/fl;Alb-Cre or control mice looking at differences in mitochondrial quantity when Mllt3 is
knocked out in the hepatocytes. In addition, age and sex differences in mitochondrial quantity
were studied. In male Mllt3fl/fl;Alb-Cre mice, at 5 weeks of age there was no difference in the
quantity of mitochondria seen by the expression of the mitochondrial gene Cytochrome B (Cyt B)
compared to the control gene Actin B (Act B). At 10 and 13 weeks, mitochondrial quantity was
increased in the liver specific Mllt3 knockout mice. At 21 weeks there was a reduction in
mitochondrial quantity, but the quantity was again significantly increased at 25 weeks. Another
reduction in mitochondria quantity occurred in the male Mllt3 knockout mice at the 30–33-week
age range and the value was like the control mice when the mice were over a year old (53-57
weeks) (Figure 64a). In female Mllt3 Alb-Cre mice that were 5 weeks old, there was a slight, yet
significant, increase in the quantity of mitochondria. This increase was still present at 10 weeks
but was insignificant while it became significant again at 13 weeks and remained so through 21
weeks of age. When the mice were greater than a year old, the mitochondrial quantity
significantly decreased in the female liver specific Mllt3 knockout mice (Figure 64b). When
grouped by sex and irrespective of age-related differences, male liver specific Mllt3 knockout
mice showed no difference (4.7% increase) in the quantity of mitochondria while the female
knockout mice had significantly increased (68%) quantity. In addition, the female Mllt3 Alb-Cre
knockout mice had significantly increased expression compared to the male knockout (Figure
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64c). When grouped independent of both age and sex differences, there was an overall increase
(33.2%) in the quantity of mitochondria in mice with Mllt3 knocked out of the hepatocytes
(Figure 64d).

Figure 64: Quantitative DNA PCR on Mllt3ΔHep Mice Showed Variable Mitochondrial
Quantity at Different Ages in Males and Females. (a)Mitochondrial quantity in male Mllt3ΔHep
mice grouped by age. (b) Mitochondrial quantity in female Mllt3ΔHep mice grouped by age.(c)
Mitochondrial quantity regardless of age. (d) Mitochondrial quantity regardless of age and sex.
Mitochondrial quantity in Mllt1fl/fl;Alb-Cre control mice was also tested with qPCR of the
genes Act B and Cyt B. The male Mllt1 Alb-Cre knockout mice had a significant reduction in
mitochondrial quantity at 5 and 12 weeks of age. In comparison, the female Mllt1 Alb-Cre
knockout mice had increased, but not significant, mitochondrial quantity at 5 weeks that became
significant at 12 weeks (Figures 65a,b). Thus, when grouped irrespective of age-related
differences, male Mllt1 Alb-Cre knockout mice had significantly reduced (17.1% decrease)
mitochondrial while female knockout mice had significantly increased (69.7%) quantity. Also,
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there was a significant difference in mitochondrial quantity between the male and female Mllt1
Alb-Cre knockout mice (Figure 65c). When grouped regardless of both age and sex, there was a
trend towards an increase (26.3%) in mitochondrial quantity in the liver specific Mllt1 knockout
mice (Figure 65d).

Figure 65: Quantitative DNA PCR on Mllt1ΔHep Mice had Increased Quantity in Females
and Reduced Quantity in Males. (a)Mitochondrial quantity in male Mllt1ΔHep mice grouped by
age. (b) Mitochondrial quantity in female Mllt1ΔHep mice grouped by age.(c) Mitochondrial
quantity regardless of age. (d) Mitochondrial quantity regardless of age and sex.
qPCR on Mllt3 Rosa26Cre, whole body Mllt3 knockout, male mice showed a slight but
significant reduction in mitochondrial quantity at 33 weeks of post-Tamoxifen. This quantity
increased at 58 weeks, but there was a large range making it insignificant. By 64 weeks, the
increase was significant and was maintained until 95 weeks where there was a significant
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reduction in mitochondrial quantity. At the oldest age of male Mllt3 Rosa26Cre mice postTamoxifen, 116 weeks, there was no significant change in mitochondrial quantity (Figure 66a).
In female Mllt3 Rosa26Cre mice, there was a significant reduction in mitochondrial quantity at
18 weeks post-Tamoxifen injection. At 59 weeks there was no significant change, while at 63
weeks there was a slight significant reduction in mitochondrial quantity. At 82 weeks the
quantity was again similar to that of the wildtype mice (Figure 66b). When grouped regardless of
age, the male Mllt3 Rosa26Cre knockout mice had a slight significant increase (12.9%) in
mitochondrial quantity while the female knockout mice had a slight significant reduction (9.5%
decrease). There was an overall difference in mitochondrial quantity between the male and
female knockouts (Figure 66c). Since the male and female knockout mice have opposite
expression differences, when grouped irrespective of age and sex, there was no significant
change (3.1% increase) in mitochondrial quantity between the Mllt3 Rosa26Cre knockout mice
compared to the controls (Figure 66d).
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Figure 66: Quantitative DNA PCR on Mllt3Rosa26Cre Mice Showed Variable
Mitochondrial Quantity Changes in Male and Female Mice. (a)Mitochondrial quantity in
male mice grouped by age. (b) Mitochondrial quantity in female mice grouped by age.(c)
Mitochondrial quantity regardless of age. (d) Mitochondrial quantity regardless of age and sex.
Mllt1 Rosa26Cre knockout male mice showed increased mitochondrial quantity at 12and 48-weeks post-Tamoxifen treatment, but by 52 weeks, there was reduced mitochondrial
quantity (Figure 67a). In female Mllt3 Rosa26Cre knockout mice, there was an insignificant
increase in mitochondrial quantity at 12 weeks post-Tamoxifen that was then significant at 34
weeks. At 47 weeks post-Tamoxifen treatment, there was an insignificant decrease in
mitochondrial quantity, but at the final age of 52 weeks post-Tamoxifen, there was a slight yet
significant increase in the quantity (Figure 67b). Grouped irrespective of age, male Mllt3
Rosa26Cre knockout mice had increased (43.9%) mitochondrial quantity that was significantly
higher than the female knockout mice that had no change (0.2% increase) in quantity (Figure
67c). When grouped regardless of both age and sex differences, there was no significant change
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(13.7%) in mitochondrial quantity in the Mllt3 Rosa26Cre knockout mice compared to the
controls (Figure 67d).

Figure 67: Quantitative DNA PCR on Mllt1Rosa26Cre Mice Showed Gradually Decreasing
Mitochondrial Quantity in Male Mice and Variable Changes in Female. . (a)Mitochondrial
quantity in male mice grouped by age. (b) Mitochondrial quantity in female mice grouped by
age.(c) Mitochondrial quantity regardless of age. (d) Mitochondrial quantity regardless of age
and sex.
The Mllt1/3 Rosa26Cre double whole-body knockout male mice had significantly
increased mitochondrial quantity at 12 weeks post-Tamoxifen that was then significantly
decreased at 30 weeks (Figure 68a). Similar results were seen in the female Mllt1/3 Rosa26Cre
knockout mice where there was a significant increased mitochondrial quantity at 12 weeks postTamoxifen followed by reduced quantity again at 30 weeks. At 36 weeks post-Tamoxifen
injection, there was a large range with an insignificant increase in mitochondrial quantity (Figure
68b). Irrespective of age differences in mitochondrial quantity, both male and female Mllt1/3
Rosa26Cre knockout mice trended towards increases in mitochondrial quantity (15.3% in males,
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21% in females) (Figure 68c). Regardless of both age and sex differences however, there was
increased (20.3%) mitochondrial quantity in the double knockout mice (Figure 68d).

Figure 68: Quantitative DNA PCR on Mllt1/3Rosa26Cre Mice Showed Increased
Mitochondrial Quantity at 12 Weeks and Reduced Quantity at 30 Weeks in Male and
Female Mice. (a)Mitochondrial quantity in male mice grouped by age. (b) Mitochondrial
quantity in female mice grouped by age.(c) Mitochondrial quantity regardless of age. (d)
Mitochondrial quantity regardless of age and sex.

CHAPTER FOUR
DISCUSSION
Mllt3-Dependent Expression of Hexose and Monosaccharide Metabolism-Related Genes
Before analyzing Mllt3;Alb-Cre mice for changes in the expression of genes identified as
being differentially expressed in mice with a liver specific Mllt3 liver deletion, qRT-PCR for
Mllt3 expression was performed to establish that a good knockout in hepatocytes occurred.
RNA-sequencing of liver RNA isolated from 10-13-week-old Mllt3;Alb-Cre and control mice
identified genes that were significantly differentially expressed upon the liver specific Mllt3
deletion. The results from qRT-PCR experiments indicate that Mllt3 could influence hexose and
monosaccharide metabolism in the liver, but it is not yet known if it is a direct or indirect effect.
Overall, the qRT-PCR results agree with RNA-sequencing data at 13 weeks of age in male and
female mice but differed at some of the additional ages of mice examined. In general, at younger
ages there was more variability or range in gene expression while the older age ranges either had
expression that was not significantly different than control mice or had opposite expression than
earlier ages. This hints that there may be something else compensating for the loss of Mllt3 in the
liver.
Mllt3-Dependent Expression of Genes Relevant to Pck1
Pck1 is the gene critical for the initial step of gluconeogenesis where oxaloacetate from
The Citric Acid Cycle is converted to phosphoenolpyruvate, an intermediate molecule of
glycolysis. Pck1, as well as multiple other genes that influence Pck1 were found in our previous
RNA-seq experiment to have significantly altered expression following liver-specific Mllt3
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knockout. RNA-sequencing data indicated that at 10-13 weeks of age, male Mllt3;Alb-Cre mice
had reduced Pck1 expression. Several genes from the RNA-seq data influence expression of
Pck1. The gene Rorc is an activator of Pck1 and was increased in expression in RNA-seq results.
Onecut1 is an inhibitor that was increased in expression based on the RNA-seq data.
Additionally, the gene Per2 inhibits PPAR-γ, which forms a heterodimer with RXRa and
promotes Pck1 activity, and was increased in expression in the RNA-seq data. The gene Wdtc1
plays a role in the control of lipid accumulation and indirectly affects Pck1 in gluconeogenesis
through the inhibition of part of the Pck1 activator PPAR-γ. Expression was decreased in the
male Mllt3;Alb-Cre mice in the RNA-seq data. The final inhibitor of Pck1 that was studied was
Irs2 which from the literature also inhibits PPAR-γ and Pck1. Irs2 in the RNA-sequencing data
was only affected by a liver specific Mllt3 knockout in female mice.
Pck1 and Related Gene Expressions
I performed qRT-PCR of Pck1 and of other genes that influence Pck1 function, looking
at age and sex related differences. For Pck1, qRT-PCR data showed no significant change at 10
weeks and an increase in expression at 13 weeks relative to age- and sex-matched controls in
male and female Mllt3ΔHep Mice. There was also reduced expression that occurred at 21-25
weeks, but expression normalized again at the oldest age range in male mice, around 1 year.
These differences in Pck1 expression could be due to the changing expression of each of the
activators or inhibitors of Pck1 at each time-point. In male Mllt3ΔHep mice, Rorc expression was
increased until the 53–57-week range while it was only increased at 21 weeks in female
knockout mice. The inhibitor Onecut1 had significantly increased expression 30-33 weeks in
male Mllt3ΔHep mice while expression in female mice was again only increased at 21 weeks. In
addition, the expression of the inhibitor Per2 was increased statistically significantly up until 53-
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57 weeks in male Mllt3ΔHep mice and remained increased in female knockout mice throughout
the age points. Wdtc1 expression from qRT-PCR showed an increase in expression at greater
than 21-25 weeks of age. Female Mllt3ΔHep mice in contrast showed increased expression at
multiple time points and a reduction at 21 weeks. The final inhibitor Irs2 had increased
expression in male knockout mice at 10 and 13 weeks and a reduction in expression at 21-25
weeks. Female mice only had reduced Irs2 expression at 10-13 weeks otherwise there was no
significant difference. Based on the literature, the inhibitors of PPAR-γ, Per2, Irs2, and Wdtc1,
would inhibit Pck1 activity at the 10-13 weeks which was not observed in the qRT-PCR data but
was in the RNA-seq results.
When Pck1 expression was at its highest in male Mllt3ΔHep mice, Rorc expression was
still significantly increased while the inhibitors Onecut1, Per2, and Irs2 were all increased as
well. Possibly, increased Rorc expression was able to overcome the three inhibitors of Pck1 and
result in increased expression at that age. In female Mllt3ΔHep mice , Pck1 expression was slightly
increased at 13 weeks, although there was just one pair of female mice at that age, and had
similar expression to the control mice. Rorc expression was unchanged also at the same time
period while Onecut1 was only decreased at 13 weeks, Per2 was slightly increased in expression,
and Irs2 was decreased in expression. Overall, the balance of the activator and inhibitors in
female Mllt3ΔHep mice resulted in no significant change in Pck1 expression. When Pck1
decreases in expression at 21-25 weeks old in male mice, Rorc expression was only minimally
increased compared to the control. In addition, Onecut1 was significantly increased in expression
while Per2 remained increased and Irs2 decreased in expression. Thus, there was higher overall
expression of all the Pck1 inhibitors to potentially dominate over the activator Rorc. When
grouped regardless of age and only based on the effect of sex on expression, Pck1 expression did
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not change between the Mllt3ΔHep mice and the controls which hints that Mllt3-dependence on
expression can be overcome with increased time post-Mllt3 deletion which could relate to the
activator and inhibitor effects at the same ages. Rorc and Per2 expression were increased in both
male and female Mllt3ΔHep mice when grouped regardless of sex possibly indicating they are
more affected by the knockout of Mllt3 in the liver. In addition, Onecut1 expression was only
increased significantly in male Mllt3ΔHep mice when grouped regardless of sex showing a sex
specific difference in expression. Finally, Irs2 was not significantly changed in expression in
both sexes grouped regardless of sex which could indicate there is another underlying factor
affecting its’ expression. When grouped regardless of both age and sex, Rorc, Onecut1, and Per2
all were increased in expression while Pck1 and Irs2 were not significantly changed. This could
again be evidence for the effect of Mllt3 on expression of genes Rorc, Onecut1, and Per2 in the
liver specific knockout while Pck1 and Irs2 may be more indirect effects of the knockout.
Overall, in control mice, Rorc, Onecut1, Per2, and Irs2 influence the expression of Pck1
resulting in homeostatic gluconeogenesis occurring. In young male Mllt3ΔHep mice however, the
high expression of Rorc may out compete the inhibitors and increase Pck1 expression which
could influence gluconeogenesis. Old Mllt3ΔHep mice had lower expression of Rorc and higher
expression of the inhibitors of Pck1 resulting in reduced expression of Pck1 again influencing
downstream gluconeogenesis. The normal role of Mllt3 in hexose metabolism may be to assist in
balancing the expression of genes influencing Pck1 and maintaining monosaccharide
homeostasis.
Mllt3-Dependent Expression of Genes Relevant to Gck and Glycolysis
Another part of hexose metabolism influenced by the differentially expressed genes from
the RNA-sequencing data is the first step of glycolysis where glucose is converted to glucose-6-
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phosphate. One of the critical enzymes for this is Glucokinase which had increased expression in
the RNA-sequencing data of Mllt3ΔHep male mice. Rorc promotes Glucokinase activity while Irs2
inhibits it thus resulting in a balancing of expression between activators and inhibitors.
Gck expression was significantly increased in male mice until 21-25 weeks of age where
it was no longer statistically different from the control mice. While female mice had reduced
Gck expression at 10 weeks that was then increased at 13 and 21 weeks of age. Like previously
states, both Rorc and Irs2 have increased expression at 10 and 13 weeks of age in male Mllt3ΔHep
mice so they would be competing for Gck expression with either Rorc having higher expression
or another outside factor influencing the increase in Gck. Female Mllt3ΔHep mice had reduced
Irs2 expression at 10 and 13 weeks and increased Rorc expression at only 21 weeks. This may
explain why Gck is reduced in expression at 12 weeks in female mice and increased at 21 weeks.
In addition, Gck expression was increased in male Mllt3ΔHep mice when grouped regardless of
age while the female mice had no significant difference. Irs2 was only indicated as being
significantly affected by the liver-specific knockout of Mllt3 in female mice in the RNAsequencing data which contradicts what was observed in the qRT-PCR results but could indicate
why there was only a sex specific change in Gck expression in male mice.
Beta Oxidation and Glutathione Synthesis in Mllt3ΔHep Mice
The gene Foxa2 functions in Beta Oxidation of fatty acids into Fatty Acyl-CoA in the
mitochondria that will be shortened by two carbons into Acyl-CoA and eventually transformed
into Acetyl-CoA. This Acetyl-CoA can then enter The Citric Acid Cycle. Foxa2 expression was
increased in the RNA-seq data of male Mllt3;Alb-Cre mice aged 10-13 weeks. Another gene
which can indirectly be connected to The Citric Acid cycle is Gclc. Glutamate-Cysteine Ligase is
the critical rate-limiting enzyme in glutathione synthesis where glutamate and cysteine are
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combined, and energy is consumed. This source of glutamate can come from the amino acid
glutamine or from an intermediate of The Citric Acid Cycle, α-ketoglutarate. RNA-sequencing
results indicated that Gclc expression was decreased in male Mllt3ΔHep mice.
qRT-PCR confirmed the increased expression of Foxa2 in male Mllt3ΔHep mice at 10
weeks, and additional increases in expression at 5 and 21-25 weeks. Female Mllt3ΔHep mice
showed increased Foxa2 expression at 5 and 21 weeks of age, and a difference in Foxa2
expression occurred in both male and female knockouts regardless of age as well. Overall, the
RNA-sequencing results and confirmation with qRT-PCR indicates that the liver specific
knockout of Mllt3 affects Foxa2 expression which could alter homeostatic Fatty Acid Beta
Oxidation and the downstream production of Acetyl-CoA and ultimately The Citric Acid Cycle.
No significant difference in Gclc occurred at any age group in the male Mllt3ΔHep mice. The
female Mllt3ΔHep mice had increased expression of Gclc at 5 and 53-57 weeks, and additionally
had increased expression when grouped regardless of age. While the liver specific deletion of
Mllt3 may influence Gclc, it does not appear to have a highly significant effect at any age group
in male or female mice. It may be that other factors influence Gclc resulting in insignificant
changes in expression and function.
Gene Expression of B4galt1 in the N-Glycan Processing Pathway in Mllt3ΔHep Mice
The final gene identified by RNA-seq, which I studied in more detail using qRT-PCR,
was B4galt1. B4galt1 catalyzes the transfer of galactose conjugated to UDP and Nacetylglucosamine to the oligosaccharide acceptor within the Golgi Apparatus. Expression was
increased in male Mllt3ΔHep mice from RNA-sequencing data which was observed in the qRTPCR results up to the 53–57-week age range. Female knockout mice only showed differences at
10 and 21 weeks of age. Grouped regardless of age the male Mllt3ΔHep mice had increased
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expression of B4galt1 while female mice had no change indicating that this could be a sex
specific difference occurring as the result of the liver specific Mllt3 deletion. This increase in
expression could result in changes to the elongation step of the N-glycan processing pathway.
Expression of the Close Homolog Mllt1 in Mllt1ΔHep Mice
A liver specific knockout of Mllt3 affects the expression of these genes of the previously
mentioned hexose metabolism associated genes, but with age and sex specific differences. It is
possible there are other regulatory components that are not affected by this knockout and may
compensate for the loss of Mllt3. One such gene could be the close homolog of Mllt3, Mllt1. In
male Mllt3ΔHep mice, there was an increase in Mllt1 expression between 10-13 weeks of age
while female mice had increased expression at 13 and 21 weeks, but the number of mice studied
at 13 weeks was only one pair. More experiments need to be performed in the future to study the
role of Mllt1 when Mllt3 is knocked out, but the increase of Mllt1 expression in male mice
during the age range that RNA-sequencing was done could hint at a function to attempt to bring
gene expression back to homeostatic ranges and functions. This could also correlate with the fact
that most genes show less differences in expression at older age ranges but are more variable at 5
weeks before Mllt1 expression increases.
Mllt1;Alb-Cre Knockout
Pck1 and Relevant Gene Expression in Liver Tissue from Mllt1ΔHep Mice
In male Mllt1ΔHep knockout mice, there was no change in the expression of Pck1 at both 5
and 12 weeks of age while the activator and repressors were all statistically different in at least
one of the age groups. The female knockout mice had reduced expression at both ages. This
again could be contributed to the balance of activators and repressors also possibly affected by
Mllt1ΔHep. Rorc expression, an activator of Pck1, was again increased in the male Mllt1ΔHep mice
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and at 5 weeks in the female knockout mice. The inhibitors of PPAR-γ, Wdtc1 and Per2, were
both decreased in expression at 5 weeks in male Mllt1ΔHep mice. This Per2 expression was the
opposite of what was seen at 5 weeks in male Mllt1ΔHep mice. This would result in less inhibition
of PPAR-γ and consequently Pck1 from this specific track. Irs2 expression was increased at 5
weeks in both male and female Mllt1 liver specific knockouts which would inhibit PPAR-γ and
balance the effects of reduced Wdtc1 and Per2 expression. This would also work against the
increased Rorc expression on Pck1. Onecut1 expression was again increased in male Mllt1ΔHep
mice, similar to Mllt3ΔHep mice, while female knockout mice had reduced expression at 12
weeks. Again, this increased Onecut1 expression would compete with other factors influencing
Pck1 expression and perhaps gluconeogenesis.
Changing Expression of Genes Associated With Gck and Glycolysis in Mllt1ΔHep Mice
Glucokinase expression was decreased in male and female Mllt1ΔHep mice at 12 weeks
and was increased at 5 weeks in the female knockouts. The changing expressions of Rorc and
Irs2 in male and femaleMllt1ΔHep mice, two opposing influences on Gck, resulted in only the
slight change in Gck expression which may not be enough to affect glycolysis. Overall, there are
less changes in Gck expression in Mllt1ΔHep mice than in Mllt3ΔHep mice indicating Mllt3 may
normally influence Gck, and subsequently glycolysis, more than Mllt1.
Mllt1ΔHep Influences Genes Factoring in The Citric Acid Cycle
Foxa2 expression was increased in male Mllt1ΔHep mice and decreased in female
knockouts showing a sex specific difference in expression in Mllt1ΔHep mice. Opposite effects
could possibly be observed on Beta Oxidation and Acetyl-CoA production as a result. The
expression of Gclc and B4galt1 in male and female Mllt1ΔHep mice was similar to the qRT-PCR
results in Mllt3ΔHep mice further supporting the idea that it is not highly affected by a knockout of
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Mllt3 or by the close homolog Mllt1.This could indicate that Gclc and B4galt1 are influenced by
other factors not studied in my thesis research project.
Mllt3 Expression in Mllt1ΔHep Mice
Interestingly, the expression of Mllt3 was not changed in male Mllt1ΔHep mice but was
increased in 5-week-old female knockouts and then decreased at 12 weeks of age. When grouped
regardless of age, there was no change in the expression of Mllt3 in male and female Mllt1ΔHep
mice indicating that the changes in gene expression previously described are due to just changes
in the expression of Mllt1 in the liver. In addition, Mllt3 did not appear to have altered
expression to compensate for the loss of Mllt1, thus there may not be a feedback loop regulating
their expression. .
Mllt3;Rosa26Cre Hexose Metabolism Gene Expression
Comparison of Mllt3-Dependent Gluconeogenesis Pathway Genes in Liver Tissue from
Liver-Specific and Whole-Body Mllt3 Knockout Mice
The expression of the genes of interest from the RNA-sequencing results in Mllt3
Rosa26Cre mice primarily demonstrated differences in the male Mllt3 whole-body knockout
mice and not the females of the same age. Pck1 expression was decreased in male Mllt3
Rosa26Cre mice. Looking at an activator of Pck1, Rorc, expression was increased in male
knockout mice 58/59 weeks post-Tamoxifen injection. Expression of the studied inhibitors of
PPAR-γ were as follows: Wdtc1 and Per2 were both slightly increased in expression but not
significantly changed while Irs2 expression was slightly decreased in the male Mllt3 Rosa26Cre
mice and significantly increased in the female knockouts. Overall, the expression of PPAR-γ was
more than likely not affected by the genes I analyzed from the RNA-seq data. The increase in
Irs2 expression in female Mllt3 Rosa26Cre mice could cause some inhibition of Pck1 activity
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more directly but is probably negated by Rorc or other activators since there was no change in
Pck1 expression. In addition, the final inhibitor of Pck1 studied, Onecut1, had increased
expression in male whole-body Mllt3 knockout mice while the female knockouts showed no
overall difference. Thus, the reduction in the expression of Pck1 appears to be driven by the
increased expression of the inhibitor Onecut1 since the other more indirect inhibitors showed no
changes in gene expression, and the change in Onecut1 expression was able to overpower the
activation function of Rorc. Again, this shows the relationship between Mllt3 and hexose
metabolism, specifically gluconeogenesis, within the whole-body knockout mice 58/59 weeks
post-Tamoxifen injection. The fact that many of these genes are not significantly affected by a
whole-body Mllt3 knockout may be due to the age of the whole body knockout mice studied or
due to the compensatory pathways in additional tissues to contribute to homeostatic regulation in
the liver.
Glucokinase Functioning in Glycolysis in Mllt3;Rosa26Cre Knockouts
In addition to looking at how gluconeogenesis was affected by a whole-body Mllt3
knockout, the gene associated with the first step of glycolysis Glucokinase was also studied and
was found to be unchanged in this knockout model. While there was a slight increase in
expression, it was not significant and could be the result of the slight increase in expression of
Rorc accompanied by the small reduction in the inhibitor Irs2. Overall, glycolysis would largely
be unaffected by this gene alone.
The Effects of a Whole Body Mllt3 Knockout on Genes Affecting Factors Entering The
Citric Acid Cycle and Mllt1 Expression
Foxa2 expression had similar expression to Gck. Both Gclc and B4galt1 expression were
increased in the male Mllt3 Rosa26Cre mice indicating that they were affected by the knockout
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of Mllt3 in the whole-body and not just in the liver. Interestingly, female Mllt3 Rosa26Cre mice
had increased Mllt1 expression while male knockouts did not. This could explain why the
majority of the genes of interest are unaffected in the female Mllt3 Rosa26Cre mice because
Mllt1 could potentially compensate for the loss of the close homolog Mllt3. Like previously
stated, more experiments are needed in the future to observe if any of these genes of interest are
direct targets of Mllt3 or Mllt1 in the whole-body or the liver-specific Alb-Cre knockouts.
Hexose Metabolism Gene Expression in Mllt1;Rosa26Cre Mice
Genes Associated with Pck1 and Gluconeogenesis in Mllt1;Rosa26Cre Mice
The gluconeogenesis pathway appears to be affected in an Mllt1 whole-body knockout
mouse model because both male and female knockouts had increased expression of Pck1.
Interestingly, Rorc expression was only slightly increased in male Mllt1 Rosa26Cre mice while
the opposite was observed in the female knockouts indicating that some other factor not being
studied may impact Pck1 expression. In addition, Wdtc1 and Per2 were not significantly changed
upon knockout of Mllt1 suggesting that they may be associated with a liver specific effect of
deletion since Mllt1;Alb-cre mice had changes in gene expression but at younger ages. Irs2 and
Onecut1 were increased in both male and female Mllt1;Rosa26Cre mice but only statistically
significantly so in the male knockouts again showing a sex specific effect. Either the function
and expression of the Pck1 activator Rorc overcomes the inhibitors Irs2 and Onecut1 resulting in
increased Pck1 expression in both male and female Mllt1;Rosa26Cre knockout mice, or Pck1
could be influenced by other factors resulting in increased expression and possibly occurrence of
the first reaction of gluconeogenesis. Overall, it appears a whole-body knockout of Mllt1 is
affecting some of the genes associated with gluconeogenesis to an extent.
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Glycolysis in Mllt1;Rosa26Cre Knockouts
While Pck1 activity in gluconeogenesis may be affected by a whole-body Mllt1 knockout
in male mice, Gck expression for the first reaction in glycolysis is not significantly changed. The
inhibitor Irs2 had increased expression while the activator Rorc was also increased. Likely, the
functions of the two genes negated each other resulting in no overall change in Gck expression
which could result in unchanged glycolysis as well. In contrast, the female Mllt1 Rosa26Cre
mice had a highly statistically significant reduction in Gck likely due to the fact that the activator
Rorc was reduced while the inhibitor Irs2 was slightly increased in expression. Combined with
the information that Pck1 expression in female Mllt1 Rosa26Cre knockout mice was increased
while Gck was reduced, could indicate that either the lower glycolysis rate is resulting in more
gluconeogenesis to produce the same amount of glucose, or the other way around that more
gluconeogenesis is occurring so less glycolysis has to occur. Again the qRT-PCR results of the
genes Irs2 and Rorc and how they play into glycolysis support the idea that an Mllt1 whole-body
knockout can still cause differential expression in genes from Mllt3ΔHep since it is a close
homolog of Mllt3.
Genes Feeding into the Citric Acid Cycle and Mllt3 in Mllt1 Rosa26Cre Mice
Intriguingly, the genes B4galt1 and Gclc showed no significant change in expression in
Mllt1 Rosa26Cre male or female mice even though, they have both been identified as direct
targets of MLLT3 by Chip-Seq in HeLa cells. Since there were no changes in expression
observed in liver tissue following Mllt1 deletion, these genes may be specific targets of only
Mllt3 and not of the homolog Mllt1. The gene Foxa2 showed increased expression in male Mllt1
Rosa26Cre knockout mice which in theory could cause more availability of Acetyl-CoA to enter
The Citric Acid Cycle allowing for more gluconeogenesis to occur subsequently. Again, this
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supports the theory that this Mllt1 whole-body knockout may be a sex-specific effect for certain
genes. Interestingly, male Mllt1 Rosa26Cre knockout mice had reduced expression of Mllt3 in
these older mice indicating that Mllt3 may not be what is driving the changes in expression of
these genes.
Comparison of Pck1 and Pck1 Relevant Genes Associated with Gluconeogenesis in Mllt3
and Mllt1 Rosa26Cre
Gene expression was compared between genotypes by looking at specific age points in
male and female mice. First Pck1 expression was increased in the Mllt1 Rosa26Cre in both the
male and female knockouts when compared to the whole-body and liver specific Mllt3
knockouts at 50 weeks of age or post-Tamoxifen. Possibly Mllt1 has more of an affect on Pck1
or on the genes that control its’ expression. Rorc expression is slightly reduced in the Mllt3ΔHep
male mice while it is increased in the Mllt3 Rosa26Cre male mice. In the female mice the only
change occurring across the three genotypes is a reduction in expression in the Mllt1 Rosa26Cre
female knockouts. This highlights the sex specific differences associated with gene expression
and how Mllt3 and Mllt1 may not function similarly or compensate for the loss of the other
homolog depending on the gene. Wdtc1 expression was increased in male Mllt3ΔHep knockout
mice and was slightly increased in the female Mllt3 knockout genotypes as well showing that the
whole-body Mllt1 knockout does not have the same effect on gene expression for Wdtc1.
Interestingly, Onecut1 expression differed in male knockout across all three genotypes with
Mllt3;Alb-Cre mice having reduced expression while the Rosa26Cre male knockouts both
having increased expression. In comparison, the female knockout mice did not show changes in
Onecut1 expression. Overall, this highlights not only the sex specific differences associated with
Onecut1 expression depending on the knockout, but also it shows that Mllt3 knocked out in only
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the liver results in opposite expression of Onecut1 compared to the whole-body Mllt3 knockout.
More sex-specific differences were observed when comparing Per2 expression at 50 weeks.
Male Mllt3 or Mllt1 mice did not show differences in Per2 expression while female Mllt3ΔHep
knockout mice had higher expression and statistically different from the Mllt1 Rosa26Cre
knockout mice. This also indicates that the expression of Per2 in female mice may be dependent
on the expression or loss of Mllt3. Changes in Irs2 expression differed between male and female
mice with the male Mllt1 Rosa26Cre knockouts having higher expression compared the Mllt3
knockouts while female Mllt3 Rosa26Cre mice showed an increased expression. More
experiments will need to be done in the future to study which of these are direct targets of Mllt3
and/or Mllt1 and to explore more age groups in the Rosa26Cre mice to test for more age
associated differences.
Hexose Metabolism Gene Expression Comparison Between Mllt3 Alb-Cre and Mllt3/Mllt1
Rosa26Cre Mice
B4galt1 only had a difference in expression in the male Mllt3 Rosa26Cre knockout mice
when compared to the liver specific Mllt3 knockouts. Another sex-specific difference occurred in
Gclc. Male knockout mice had unchanged expression of Gclc in all three genotypes while female
Mllt3ΔHep mice had higher expression compared to the other two genotypes. This shows the sex
effect of the liver specific knockout of Mllt3 in female mice at 50 weeks of age while the male
Alb-Cre knockout had more normalized Gclc expression at this age. Another sex effect was
observed in Foxa2 and Gck when the male Mllt1 Rosa26Cre mice had higher expression while
the female mice of the same genotype had reduced expression. This proves that both Mllt3 and
Mllt1 have sex related effects on gene expression.
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Gene Expression Comparison Between Liver-Specific Knockout of Mllt3 and Mllt1
Pck1 Relevant Genes in Gluconeogenesis Comparison in Alb-Cre Mice
Gene expression was compared between Mllt3 and Mllt1ΔHep mice at 12 weeks and 5
weeks of age. Both male and female Mllt1 knockout mice at 12 weeks of age showed reduction
in Pck1 expression compared to the Mllt3ΔHep mice while only the female Mllt1ΔHep mice still
showed this reduction at 5 weeks of age. While the female liver-specific Mllt1 knockout mice
showed this reduced expression at both age points, Rorc expression was unchanged at 12 weeks
and increased at 5 weeks. Additionally, the male mice from both sets of knockouts showed
increased Rorc expression at 5 and 12 weeks suggesting that there may be some overlapping
function between the homologs Mllt3 and Mllt1 and how they affect expression of the genes
from RNA-seq. At 12 weeks of age the only difference in expression was in the female Mllt1ΔHep
knockout mice which was not observed at 5 weeks. Furthermore, the male Mllt1ΔHep knockout
mice at 5 weeks showed a statistically significant reduction in Wdtc1 expression while the female
Mllt3ΔHep knockouts had a slight increase. The varying expressions of Wdtc1 in each genotype
highlights that the knockouts of either Mllt3 and Mllt1 have age related differences. These
differences could be due to the changes in expression of Mllt3 or Mllt1 in mice where the other
homolog is knocked out. Mllt1 expression was increased in male Mllt3ΔHep knockout mice at 10
and 13 weeks of age while expression was increased in female knockouts at 12 and 21 weeks,
keeping in mind that the 13-week age data consisted of only one matched pair of mice. Male
Mllt1ΔHep mice did not show changes in Mllt3 expression while female knockout mice had an
increase at 5 weeks and a reduction at 12. This variation in Mllt3 expression could be why gene
expression changes more in the female mice than the male mice. This is further supported by
Onecut1 expression being reduced in 12-week-old female Mllt1ΔHep mice but was not changed at
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5 weeks. Both Mllt3 and Mllt1 male knockouts had increased Onecut1 expression at 5 and 12
weeks, possibly a sex specific effect. To further observe the effects of age, sex, and close
homologs on gene expression, future experiments should look at more Mllt1ΔHep mice of older
ages to observe if similar expression changes occur. Similar changes in Per2 expression occurred
across genotypes at both 5 and 12 weeks. At 12 weeks, male and female Mllt3ΔHep knockouts had
increased Per2 expression while the Mllt1 knockouts showed no change. At 5 weeks, the
increased Per2 expression remained in the Mllt3 Alb-Cre knockouts while the Mllt1ΔHep mice
had reduced expression. The expression of Per2 appears to be more influenced by what gene is
knocked out or what homolog is still present rather than a sex difference. Another gene showing
differences depending on age is Irs2. In female knockout mice at 5 weeks of age there was a
slight increase in expression in the Mllt3 and Mllt1ΔHep mice, but at 12 weeks both genotypes had
highly statistically significant reductions in expression. Irs2 was identified as being reduced only
in female mice from the RNA-sequencing data done on Mllt3ΔHep mice, but the qRT-PCR shows
that expression changes depending on age as well. In addition, Irs2 may be acted upon by both
Mllt3 and Mllt1 because of the similar changes in expression in either knockout, but more
experiments need to be done to fully see this effect. 5-week-old male mice showed increased Irs2
expression in the liver specific Mllt1 knockout, but by 12 weeks, the opposite was seen with the
Mllt3 liver knockout showing increased expression. Based on the RNA-seq data and qRT-PCR
results, expression of the genes of interest is affected by sex and by age of the mouse depending
on the gene and also what the genotype of the mouse is.
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Glycolysis and Genes Whose Products Feed into the Citric Acid Cycle in Mllt ΔHep and
Mllt3ΔHep Mice
Further highlighting age and sex differences in expression between each genotype,
B4galt1 expression at 5 weeks of age in all genotypes and both sexes expect in the female
Mllt3ΔHep mice. At 12 weeks however, the male Mllt3ΔHep mice were still increased in expression
while the Mllt1 were not, and both genotypes in the female mice had reduced expression. Thus,
the loss of Mllt3 or Mllt1 from mouse livers results in altered gene expression dependent on the
sex of the mice, and expression is not stagnant, it changes over time as the mouse ages. Gclc
expression similarly proved this point because both genotypes in the male knockout had
unchanged expression at both ages, but female knockouts showed changes in expression. At 5
weeks, both genotypes in female mice had slightly increased expression of Gclc, but at 12 weeks
only the Mllt1ΔHep mice still had the same increase. Therefore, at a young age, Gclc expression in
female mice appears to be more affected than male mice by a knockout of Mllt3 or Mllt1. The
expression of Foxa2, the gene associated with Beta Oxidation, had increased expression in both
genotypes in the male mice and in the Mllt3ΔHep female mice at 5 weeks of age. This expression
in male mice was maintained at 12 weeks, but the female mice only showed a slight reduction in
expression in the Mllt1ΔHep knockouts instead. In the case of Foxa2, male mice seem to be more
affected by the knockout of either Mllt3 or Mllt1, so maybe the homologs have slight
overlapping functions regarding this gene. The final gene Glucokinase was most affected by a
liver specific Mllt3 knockout in male mice while the Mllt1ΔHep knockout had only a small
decrease in expression at 12 weeks. Glucokinase expression was only changed in female mice
when Mllt1 was knocked out in the liver with an increase at 5 weeks and a decrease at 12.
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Overall, both Mllt3 and Mllt1 liver specific knockouts affect gene expression differently
depending on age and sex of the mouse.
Effect of a Liver Specific Mllt3 Knockout On Liver Mitochondria Function
Based on the results from the Seahorse Assays done on male and female Mllt3ΔHep mice
that were between 55 and 60 weeks of age, mitochondrial function is not affected by a liver
specific knockout of Mllt3. While looking at individual comparisons between matched mice
could show differences in the mitochondrial function, it really depended on what samples were
being compared to each other. In both the male and female mice, there was one pair of mice that
did not have changes in mitochondrial function in the Seahorse Assay while another pair had
increased function, and a third matched pair had decreased function following Mllt3 deletion.
Additionally, the one Seahorse Assay done on female mice that were 6 weeks old also showed
no difference in mitochondrial function between the Mllt3ΔHep knockout and control. Seahorse
Assays had to be done using freshly enriched mitochondria and the amount of mitochondria
protein used for Seahorse were measured by a Coomassie Protein Assay. However, I was unable
to assess mitochondria protein enrichment by Western Blot until after the Seahorse assay due to
the time required for Western. Western Blot of mitochondria fractions I had used for Seahorse
Assay showed that mitochondria were enriched in the samples, but did not all have equivalent
amounts of mitochondria protein. Most of the pairs used for Seahorse Assay had similar
enrichment, thus Seahorse functional data reflected similar input amounts of mitochondria.
However, for those that did not, adjustments were made from calculations based on enrichment
of the mitochondrial membrane marker ATP5a in the Western Blot. Overall, there was no
significant change in mitochondrial function in Mllt3 Alb-Cre knockout male and female mice

119

older than 50 weeks, and female mice at 6 weeks. More experiments will have to be done in the
future to look at more age, sex, and genotype comparisons.
Liver Mitochondrial Number is Affected by a Mllt3 Knockout in the Liver
While mitochondrial function was not consistently affected by a liver specific Mllt3
knockout, there was still a change in mitochondrial quantity in both male and female knockout
mice. The Seahorse Assays were done on male and female Mllt3ΔHep mice greater than 50 weeks
old age, but qPCR shows that there was little or very slight changes in mitochondrial quantity in
the male and female group by this age. The one Seahorse Assay performed on 6-week-old female
Mllt3ΔHep mice also showed no difference in mitochondrial function and there was again only a
small decrease in mitochondrial quantity, either not enough to affect function or the remaining
mitochondria were able to compensate for the loss. At younger ages, especially around 21-25
weeks of age, there were more significant changes in mitochondrial quantity. More Seahorse
Assays in the future could be done on younger aged mice to test if mitochondrial quantity differs
with age.
Comparison of Liver Mitochondrial Quantity in Mllt3 Knockout Mice
Compared to Mllt3ΔHep male mice, mitochondrial quantity in male Mllt3;Rosa26Cre still
differed at older ages, keeping in mind the N of 1. Female mice also showed a reduction in
mitochondrial quantity at 63 weeks, but not at the other time-points. While acknowledging that
many of these older ages are represented by only a single matched pair of mice, maybe a wholebody knockout of Mllt3 has more of an effect on liver mitochondrial function at older ages than a
liver specific Mllt3 knockout does. Again, more experiments will need to be done in the future to
test this theory.
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Liver Mitochondrial Quantity in Mllt1 Knockout Mice Compared to Mllt3 Knockout Mice
Mitochondrial quantity in Mllt1ΔHep mice did not differ in male mice and only in female
mice at 12 weeks. Only small changes in mitochondrial number were also observed in male and
female Mllt3ΔHep mice as well. Interestingly, at 12 weeks in the male Mllt1;Rosa26Cre there was
a significant increase in mitochondrial quantity, but again only an N of 1, and as the older mice
were assessed, the quantity decreased. Increases in quantity were also observed in female
Mllt1;Rosa26Cre mice at 34 and 52 weeks. The double knockout Rosa26Cre male and female
mice had increased mitochondrial quantity at 12 weeks like the male Mllt1;Rosa26Cre mice and
a reduction at 30-33 weeks like in the male Mllt3;Rosa26Cre and Alb-Cre mice. Again, it seems
differences in mitochondrial quantity may be more common in the Rosa26Cre mice at older ages
than the Alb-Cre mice, but future experiments need to be done to study this further by using
older male and female Mllt3 and Mllt1 mice.
Conclusions and Future Directions
The liver specific knockout of Mllt3 functions in regulating the expression of genes that
maintain homeostatic hexose metabolism and influences mitochondrial quantity. The expression
of genes identified from RNA-Sequencing differed by age and sex when Mllt3 was knocked out.
Gene expression also differed when compared to Mllt1;Alb-Cre or whole-body knockout mouse
models. A compensatory function of Mllt1 may exist and compensate for the loss of Mllt3 in the
livers of knockout mice. Future experiments need to be done to analyze if these genes are direct
or indirect targets of MLLT3. Mitochondrial quantity was highly variable across different age
groups and sex in the Mllt3;Alb-Cre while mitochondrial function was not consistently changed
at one year of age in both sexes. Overall, a knockout of Mllt3 within the liver affects genes
associated with hexose metabolism and the quantity of liver mitochondria.
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Table 5: Summary of Hexose Gene Expression Data and Mitochondrial Function. Synopsis
of gene expression and mitochondrial quantity in Mllt3ΔHep, Mllt1ΔHep, Mllt3;Rosa26Cre, and
Mllt1;Rosa26Cre mice by sex. Red indicates reduced expression in the knockout while green is
increased expression.
Mllt3 Rosa26Cre
Mice

Mllt1 Rosa26Cre
Mice

Mllt1/t3
Rosa26Cre Mice

Female

Male

Female

Male

Female

Male

Female

12
Weeks

5, 12
Weeks

1 Year

No
Change

1 Year

1 Year

-

-

21
Weeks
10
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21
Weeks
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-

-
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Change
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-

-
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No
Change
No
Change

-

-
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-

-

5
Weeks

12
Weeks
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-

-
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No
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-

-
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No
Change
No
Change

1 Year
No
Change

No
Change
No
Change

-

-

-

-

10,13
Weeks

5
Weeks

No
Change

1 Year

1 Year

No
Change

-

-

-

-

1 Year

No
Change

-

-

-

No
Change

1 Year

-

-

-

-

12
Weeks

33, 95
Weeks
63, 85
Weeks

18, 63
Weeks

12, 48
Weeks
52
Weeks

34, 52
Weeks

12
Weeks
30
Weeks

12
Weeks
30
Weeks

Mllt3-AlbCre Mice
Gene ID

Pck1

Rorc

Male
13
Weeks
21
Weeks
5-30
Weeks
30-53
Weeks

Foxa2

5-30
Weeks
No
Change
5, 10, 21
Weeks
53
Weeks

Wdtc1

21, 53
Weeks

B4galt1
Gclc

Gck

Onecut1
Per2

Irs2

Mllt3
Mllt1

Mitochondrial
Quantity

5-13, 30
Weeks
5-30
Weeks
53
Weeks
5-53
Weeks
10,13
Weeks
21
Weeks

10,13
Weeks
10, 13,
25
Weeks
21, 30
Weeks

Female
13
Weeks
21
Weeks

13,21
Weeks
5, 13,
21
Weeks
58
Weeks

Mllt1-AlbCre Mice
Male

12
Weeks

5,12
Weeks
5
Weeks

No
Change
-

No
Change

12
Weeks
5
Weeks
5
Weeks
12
Weeks
5
Weeks
12
Weeks

1 Year
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